AU3821502A - Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor - Google Patents
Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor Download PDFInfo
- Publication number
- AU3821502A AU3821502A AU38215/02A AU3821502A AU3821502A AU 3821502 A AU3821502 A AU 3821502A AU 38215/02 A AU38215/02 A AU 38215/02A AU 3821502 A AU3821502 A AU 3821502A AU 3821502 A AU3821502 A AU 3821502A
- Authority
- AU
- Australia
- Prior art keywords
- benzamide
- phenylamino
- iodo
- difluoro
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 54
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 title claims description 49
- 229940124647 MEK inhibitor Drugs 0.000 title claims description 47
- 230000002401 inhibitory effect Effects 0.000 title claims description 13
- 230000011242 neutrophil chemotaxis Effects 0.000 title description 14
- -1 2 -chloro- 4 -iodo-phenylamino Chemical group 0.000 claims description 182
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 158
- 125000000217 alkyl group Chemical group 0.000 claims description 88
- 150000001875 compounds Chemical class 0.000 claims description 84
- 210000000440 neutrophil Anatomy 0.000 claims description 65
- 229910052739 hydrogen Inorganic materials 0.000 claims description 48
- 239000001257 hydrogen Substances 0.000 claims description 46
- QDLHCMPXEPAAMD-QAIWCSMKSA-N wortmannin Chemical compound C1([C@]2(C)C3=C(C4=O)OC=C3C(=O)O[C@@H]2COC)=C4[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O QDLHCMPXEPAAMD-QAIWCSMKSA-N 0.000 claims description 42
- QDLHCMPXEPAAMD-UHFFFAOYSA-N wortmannin Natural products COCC1OC(=O)C2=COC(C3=O)=C2C1(C)C1=C3C2CCC(=O)C2(C)CC1OC(C)=O QDLHCMPXEPAAMD-UHFFFAOYSA-N 0.000 claims description 42
- GFMMXOIFOQCCGU-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide Chemical compound C=1C=C(I)C=C(Cl)C=1NC1=C(F)C(F)=CC=C1C(=O)NOCC1CC1 GFMMXOIFOQCCGU-UHFFFAOYSA-N 0.000 claims description 36
- 125000003545 alkoxy group Chemical group 0.000 claims description 34
- 150000002431 hydrogen Chemical class 0.000 claims description 31
- 230000005012 migration Effects 0.000 claims description 31
- 238000013508 migration Methods 0.000 claims description 31
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 23
- 230000005764 inhibitory process Effects 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 20
- 229940043441 phosphoinositide 3-kinase inhibitor Drugs 0.000 claims description 20
- 239000012828 PI3K inhibitor Substances 0.000 claims description 19
- 125000001072 heteroaryl group Chemical group 0.000 claims description 19
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 17
- 125000005843 halogen group Chemical group 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- 239000005711 Benzoic acid Substances 0.000 claims description 16
- 229910052794 bromium Inorganic materials 0.000 claims description 16
- 125000005842 heteroatom Chemical group 0.000 claims description 16
- 201000010099 disease Diseases 0.000 claims description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- 150000002148 esters Chemical class 0.000 claims description 14
- 229910052717 sulfur Inorganic materials 0.000 claims description 14
- 150000001408 amides Chemical class 0.000 claims description 13
- 125000003342 alkenyl group Chemical group 0.000 claims description 12
- 125000004104 aryloxy group Chemical group 0.000 claims description 12
- 125000004122 cyclic group Chemical group 0.000 claims description 12
- 125000000304 alkynyl group Chemical group 0.000 claims description 11
- 229910052740 iodine Inorganic materials 0.000 claims description 11
- 230000001404 mediated effect Effects 0.000 claims description 11
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 10
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 239000011737 fluorine Substances 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 229940002612 prodrug Drugs 0.000 claims description 8
- 239000000651 prodrug Substances 0.000 claims description 8
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 125000003282 alkyl amino group Chemical group 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 4
- GUAFZVVAOQFCPJ-UHFFFAOYSA-N 5-bromo-n-(2-hydroxyethyl)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NCCO GUAFZVVAOQFCPJ-UHFFFAOYSA-N 0.000 claims description 4
- DMXADGCWZHCXBU-UHFFFAOYSA-N 5-chloro-n-(2-hydroxyethyl)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NCCO DMXADGCWZHCXBU-UHFFFAOYSA-N 0.000 claims description 4
- 201000003883 Cystic fibrosis Diseases 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- SUDAHWBOROXANE-SECBINFHSA-N PD 0325901 Chemical compound OC[C@@H](O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F SUDAHWBOROXANE-SECBINFHSA-N 0.000 claims description 4
- 230000001154 acute effect Effects 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- XKRVQEHFHLIYHN-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)-n-methyl-5-nitro-n-phenylbenzamide Chemical compound C=1C=CC=CC=1N(C)C(=O)C1=CC([N+]([O-])=O)=CC=C1NC1=CC=C(I)C=C1C XKRVQEHFHLIYHN-UHFFFAOYSA-N 0.000 claims description 3
- YZVHIDUDGXLOLY-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(3-hydroxypropoxy)benzamide Chemical compound OCCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl YZVHIDUDGXLOLY-UHFFFAOYSA-N 0.000 claims description 3
- AANZSIPSXXHMRM-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)-n-phenylmethoxybenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NOCC1=CC=CC=C1 AANZSIPSXXHMRM-UHFFFAOYSA-N 0.000 claims description 3
- ASLGKYRJGJLPAE-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-n-(2,3-dihydroxypropoxy)-3,4-difluorobenzamide Chemical compound OCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl ASLGKYRJGJLPAE-UHFFFAOYSA-N 0.000 claims description 3
- MFISPQKUQORGHB-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)-n-methyl-n-phenylbenzamide Chemical compound C=1C=CC=CC=1N(C)C(=O)C1=CC(Cl)=CC=C1NC1=CC=C(I)C=C1C MFISPQKUQORGHB-UHFFFAOYSA-N 0.000 claims description 3
- NRQYGGWYEHEXEJ-UHFFFAOYSA-N 5-chloro-n-cyclopropyl-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NC1CC1 NRQYGGWYEHEXEJ-UHFFFAOYSA-N 0.000 claims description 3
- PJCPYFYKAWDPLX-UHFFFAOYSA-N 5-fluoro-2-(4-iodo-2-methylanilino)-n-[(4-sulfamoylphenyl)methyl]benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(F)C=C1C(=O)NCC1=CC=C(S(N)(=O)=O)C=C1 PJCPYFYKAWDPLX-UHFFFAOYSA-N 0.000 claims description 3
- KCOUCDQMKMTOGV-UHFFFAOYSA-N 5-fluoro-2-(4-iodo-2-methylanilino)-n-methyl-n-phenylbenzamide Chemical compound C=1C=CC=CC=1N(C)C(=O)C1=CC(F)=CC=C1NC1=CC=C(I)C=C1C KCOUCDQMKMTOGV-UHFFFAOYSA-N 0.000 claims description 3
- CCGNHTHRIVEZPG-UHFFFAOYSA-N 5-fluoro-2-(4-iodo-2-methylanilino)-n-phenylmethoxybenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(F)C=C1C(=O)NOCC1=CC=CC=C1 CCGNHTHRIVEZPG-UHFFFAOYSA-N 0.000 claims description 3
- CLOSFYSFDCNULT-UHFFFAOYSA-N 5-iodo-2-(4-iodo-2-methylanilino)-n-phenylmethoxybenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(I)C=C1C(=O)NOCC1=CC=CC=C1 CLOSFYSFDCNULT-UHFFFAOYSA-N 0.000 claims description 3
- 208000033116 Asbestos intoxication Diseases 0.000 claims description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 3
- 206010014561 Emphysema Diseases 0.000 claims description 3
- 208000037487 Endotoxemia Diseases 0.000 claims description 3
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims description 3
- 206010063837 Reperfusion injury Diseases 0.000 claims description 3
- 206010040047 Sepsis Diseases 0.000 claims description 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 3
- 206010003441 asbestosis Diseases 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims description 3
- 208000012947 ischemia reperfusion injury Diseases 0.000 claims description 3
- UWKABBHRKJCFIS-UHFFFAOYSA-N n-(2-hydroxy-3-phenoxypropoxy)benzamide Chemical compound C=1C=CC=CC=1OCC(O)CONC(=O)C1=CC=CC=C1 UWKABBHRKJCFIS-UHFFFAOYSA-N 0.000 claims description 3
- HPFQWCKXOZLYJQ-UHFFFAOYSA-N n-but-2-enoxy-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC=CCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C HPFQWCKXOZLYJQ-UHFFFAOYSA-N 0.000 claims description 3
- 208000023504 respiratory system disease Diseases 0.000 claims description 3
- 208000011580 syndromic disease Diseases 0.000 claims description 3
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 2
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 claims description 2
- IWZZOJQMYWDXJN-UHFFFAOYSA-N 2,3,5-trifluoro-4-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C=C(C(O)=O)C(F)=C1F IWZZOJQMYWDXJN-UHFFFAOYSA-N 0.000 claims description 2
- GLQYKBQRDMOSAE-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-(1-hydroxypropan-2-yloxy)benzamide Chemical compound OCC(C)ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(F)C=C1F GLQYKBQRDMOSAE-UHFFFAOYSA-N 0.000 claims description 2
- QEIPHLNZHZGILN-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(F)C=C1F QEIPHLNZHZGILN-UHFFFAOYSA-N 0.000 claims description 2
- BZJWSLFAFFNFIW-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-3,4-difluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Br BZJWSLFAFFNFIW-UHFFFAOYSA-N 0.000 claims description 2
- AVIWCXSGNKPKKK-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-5-chloro-3,4-difluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Br AVIWCXSGNKPKKK-UHFFFAOYSA-N 0.000 claims description 2
- NYKNXVUDYAFANQ-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl NYKNXVUDYAFANQ-UHFFFAOYSA-N 0.000 claims description 2
- ZZKOQGATWBZIBF-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl ZZKOQGATWBZIBF-UHFFFAOYSA-N 0.000 claims description 2
- HRQFWZFDBBAAEB-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-(2-methoxyethoxy)benzamide Chemical compound COCCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl HRQFWZFDBBAAEB-UHFFFAOYSA-N 0.000 claims description 2
- GUKVRAXQEMSHJI-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-(3-hydroxypropoxy)benzamide Chemical compound OCCCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl GUKVRAXQEMSHJI-UHFFFAOYSA-N 0.000 claims description 2
- UHGZLNZLHYXGIL-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-[2-(2-methoxyethoxy)ethoxy]benzamide Chemical compound COCCOCCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl UHGZLNZLHYXGIL-UHFFFAOYSA-N 0.000 claims description 2
- XARHQJOJXOWHIY-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(1-hydroxypropan-2-yloxy)benzamide Chemical compound OCC(C)ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl XARHQJOJXOWHIY-UHFFFAOYSA-N 0.000 claims description 2
- BZJWWFVEWXJWDW-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-3-morpholin-4-ylpropoxy)benzamide Chemical compound C1COCCN1CC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl BZJWWFVEWXJWDW-UHFFFAOYSA-N 0.000 claims description 2
- VVEBMFSULUFWDB-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-3-phenoxypropoxy)benzamide Chemical compound C=1C=CC=CC=1OCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl VVEBMFSULUFWDB-UHFFFAOYSA-N 0.000 claims description 2
- UFTBYBWYJKAHLK-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl UFTBYBWYJKAHLK-UHFFFAOYSA-N 0.000 claims description 2
- NXUSIIDZHWMSCV-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl NXUSIIDZHWMSCV-UHFFFAOYSA-N 0.000 claims description 2
- YVSLCRVTJGUKSV-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-(cyclopropylmethoxy)-3,4,5-trifluorobenzamide Chemical compound C=1C=C(I)C=C(Cl)C=1NC=1C(F)=C(F)C(F)=CC=1C(=O)NOCC1CC1 YVSLCRVTJGUKSV-UHFFFAOYSA-N 0.000 claims description 2
- DVENTWJICBBDAJ-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-(cyclopropylmethoxy)-4-fluorobenzamide Chemical compound C=1C=C(I)C=C(Cl)C=1NC1=CC(F)=CC=C1C(=O)NOCC1CC1 DVENTWJICBBDAJ-UHFFFAOYSA-N 0.000 claims description 2
- BOWUZVRUZUWLAM-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-ethoxy-4-nitrobenzamide Chemical compound CCONC(=O)C1=CC=C([N+]([O-])=O)C=C1NC1=CC=C(I)C=C1Cl BOWUZVRUZUWLAM-UHFFFAOYSA-N 0.000 claims description 2
- SHNRDYXLGNJCOC-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-hydroxy-4-methylbenzamide Chemical compound CC1=CC=C(C(=O)NO)C(NC=2C(=CC(I)=CC=2)Cl)=C1 SHNRDYXLGNJCOC-UHFFFAOYSA-N 0.000 claims description 2
- UOPHVVWHOCFXFI-UHFFFAOYSA-N 2-(2-fluoro-4-iodoanilino)-n-hydroxy-4-nitrobenzamide Chemical compound ONC(=O)C1=CC=C([N+]([O-])=O)C=C1NC1=CC=C(I)C=C1F UOPHVVWHOCFXFI-UHFFFAOYSA-N 0.000 claims description 2
- BYNKDEUDKDVPPJ-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(2-methylprop-2-enoxy)benzamide Chemical compound CC(=C)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1C BYNKDEUDKDVPPJ-UHFFFAOYSA-N 0.000 claims description 2
- WGIDTTDBLPTUHP-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-methoxybenzamide Chemical compound CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1C WGIDTTDBLPTUHP-UHFFFAOYSA-N 0.000 claims description 2
- LUDUVSBHPMEVQH-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-propan-2-yloxybenzamide Chemical compound CC(C)ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1C LUDUVSBHPMEVQH-UHFFFAOYSA-N 0.000 claims description 2
- HNXJNPOQVWVOGW-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-propoxybenzamide Chemical compound CCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1C HNXJNPOQVWVOGW-UHFFFAOYSA-N 0.000 claims description 2
- QTCFRZPPKGEZKF-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-(4,4-dimethylpent-2-ynoxy)-3,4-difluorobenzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC#CC(C)(C)C QTCFRZPPKGEZKF-UHFFFAOYSA-N 0.000 claims description 2
- BHEYIPCYQCTTAR-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-(cyclopropylmethoxy)-3,4-difluorobenzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC1CC1 BHEYIPCYQCTTAR-UHFFFAOYSA-N 0.000 claims description 2
- LNTZEUIWPWPUGC-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-but-3-yn-2-yloxy-3,4-difluorobenzamide Chemical compound C#CC(C)ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1C LNTZEUIWPWPUGC-UHFFFAOYSA-N 0.000 claims description 2
- BZEJFQCJTPHNOF-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-cyclopentyloxy-3,4-difluorobenzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOC1CCCC1 BZEJFQCJTPHNOF-UHFFFAOYSA-N 0.000 claims description 2
- RIEBDTYRNZXSGY-UHFFFAOYSA-N 2-(4-chloro-2-fluoroanilino)-3,4-difluoro-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Cl)C=C1F RIEBDTYRNZXSGY-UHFFFAOYSA-N 0.000 claims description 2
- IKFIPTAQYKYMAC-UHFFFAOYSA-N 2-(4-chloro-2-fluoroanilino)-n-(2,3-dihydroxypropoxy)-3,4-difluorobenzamide Chemical compound OCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Cl)C=C1F IKFIPTAQYKYMAC-UHFFFAOYSA-N 0.000 claims description 2
- LFKXETJHTXTXSA-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)-5-nitrobenzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(O)=O LFKXETJHTXTXSA-UHFFFAOYSA-N 0.000 claims description 2
- FHXQAXYOKQYKHH-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC=CC=C1C(O)=O FHXQAXYOKQYKHH-UHFFFAOYSA-N 0.000 claims description 2
- PYEBOHZEONEOFB-UHFFFAOYSA-N 3,4,5-trifluoro-2-(2-fluoro-4-iodoanilino)-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1F PYEBOHZEONEOFB-UHFFFAOYSA-N 0.000 claims description 2
- SWMTZTPHGJOORL-UHFFFAOYSA-N 3,4,5-trifluoro-n-(1-hydroxypropan-2-yloxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound OCC(C)ONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1C SWMTZTPHGJOORL-UHFFFAOYSA-N 0.000 claims description 2
- KFPCHQWXSCCBND-UHFFFAOYSA-N 3,4,5-trifluoro-n-(2-hydroxybutoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1C KFPCHQWXSCCBND-UHFFFAOYSA-N 0.000 claims description 2
- FUUIHCAQKOEFHY-UHFFFAOYSA-N 3,4,5-trifluoro-n-(3-hydroxy-2,2-dimethylpropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(=O)NOCC(C)(C)CO FUUIHCAQKOEFHY-UHFFFAOYSA-N 0.000 claims description 2
- CCYWUMAAAUNDJX-UHFFFAOYSA-N 3,4,5-trifluoro-n-hydroxy-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(=O)NO CCYWUMAAAUNDJX-UHFFFAOYSA-N 0.000 claims description 2
- OJRQEHWYHIYRRZ-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(1-hydroxypropan-2-yloxy)benzamide Chemical compound OCC(C)ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F OJRQEHWYHIYRRZ-UHFFFAOYSA-N 0.000 claims description 2
- HYIXUGDJHLKVGF-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(2-phenoxyethoxy)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCOC1=CC=CC=C1 HYIXUGDJHLKVGF-UHFFFAOYSA-N 0.000 claims description 2
- ZWXXSMYLKXWUIM-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-prop-2-ynoxybenzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC#C ZWXXSMYLKXWUIM-UHFFFAOYSA-N 0.000 claims description 2
- LEYZOHZNXYPUBL-UHFFFAOYSA-N 4-chloro-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC(Cl)=CC=C1C(O)=O LEYZOHZNXYPUBL-UHFFFAOYSA-N 0.000 claims description 2
- PEZQORQECWUYJA-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)-n-methoxybenzamide Chemical compound CONC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1C PEZQORQECWUYJA-UHFFFAOYSA-N 0.000 claims description 2
- PFWAYQMMRCDJJX-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)-n-prop-2-enoxybenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NOCC=C PFWAYQMMRCDJJX-UHFFFAOYSA-N 0.000 claims description 2
- VFLRZRPXLGMONP-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)-n-prop-2-ynoxybenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NOCC#C VFLRZRPXLGMONP-UHFFFAOYSA-N 0.000 claims description 2
- COEXMYRMIABFRK-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(N)=O COEXMYRMIABFRK-UHFFFAOYSA-N 0.000 claims description 2
- IIJDQEBBOFOXKL-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(O)=O IIJDQEBBOFOXKL-UHFFFAOYSA-N 0.000 claims description 2
- HSZHWOFEZWWCOB-UHFFFAOYSA-N 4-fluoro-n-(3-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NOCCCO HSZHWOFEZWWCOB-UHFFFAOYSA-N 0.000 claims description 2
- HSDBAZASWXUUHX-UHFFFAOYSA-N 4-fluoro-n-hydroxy-2-(4-iodo-2-methylanilino)benzamide Chemical group CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NO HSDBAZASWXUUHX-UHFFFAOYSA-N 0.000 claims description 2
- RPWNJSYAWBWAFW-UHFFFAOYSA-N 5-bromo-2-(2-bromo-4-iodoanilino)-3,4-difluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Br RPWNJSYAWBWAFW-UHFFFAOYSA-N 0.000 claims description 2
- ZMFXUELOZZCDTA-UHFFFAOYSA-N 5-bromo-2-(2-bromo-4-iodoanilino)-n-ethoxy-3,4-difluorobenzamide Chemical compound CCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Br ZMFXUELOZZCDTA-UHFFFAOYSA-N 0.000 claims description 2
- SRMDAFUJVQJZFI-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl SRMDAFUJVQJZFI-UHFFFAOYSA-N 0.000 claims description 2
- YNAWORHNPLOBBU-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)-n-methyl-n-phenylbenzamide Chemical compound C=1C=CC=CC=1N(C)C(=O)C1=CC(Br)=CC=C1NC1=CC=C(I)C=C1C YNAWORHNPLOBBU-UHFFFAOYSA-N 0.000 claims description 2
- BSFZRPNXKUHUAO-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(O)=O BSFZRPNXKUHUAO-UHFFFAOYSA-N 0.000 claims description 2
- NKRZYDJKGYMRDY-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(3-methylbut-2-enoxy)benzamide Chemical compound CC(C)=CCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C NKRZYDJKGYMRDY-UHFFFAOYSA-N 0.000 claims description 2
- HCJZFECDFDVVFQ-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(3-methylpent-2-en-4-ynoxy)benzamide Chemical compound C#CC(C)=CCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C HCJZFECDFDVVFQ-UHFFFAOYSA-N 0.000 claims description 2
- IGSVYYMTMKJIDZ-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-propoxybenzamide Chemical compound CCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C IGSVYYMTMKJIDZ-UHFFFAOYSA-N 0.000 claims description 2
- CWFCDWVXNAFAHX-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-[(4-iodo-2-methylphenyl)methyl]-n-[5-(3-methoxyphenyl)-3-methylpent-2-en-4-ynoxy]benzamide Chemical compound COC1=CC=CC(C#CC(C)=CCONC(=O)C=2C(=C(F)C(F)=C(Br)C=2)CC=2C(=CC(I)=CC=2)C)=C1 CWFCDWVXNAFAHX-UHFFFAOYSA-N 0.000 claims description 2
- IEYNEIJJGQBZMU-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(1-hydroxypropan-2-yloxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound OCC(C)ONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C IEYNEIJJGQBZMU-UHFFFAOYSA-N 0.000 claims description 2
- HHYOBDFYUTXMDG-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(2-hydroxy-3-phenoxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCC(O)COC1=CC=CC=C1 HHYOBDFYUTXMDG-UHFFFAOYSA-N 0.000 claims description 2
- ALQODYTZYYARJM-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(2-hydroxybutoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C ALQODYTZYYARJM-UHFFFAOYSA-N 0.000 claims description 2
- HUXIPGAKZFWFMM-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(2-hydroxyethoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCCO HUXIPGAKZFWFMM-UHFFFAOYSA-N 0.000 claims description 2
- OKRDHHWCFHEDRY-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(furan-3-ylmethoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCC1=COC=C1 OKRDHHWCFHEDRY-UHFFFAOYSA-N 0.000 claims description 2
- XXSSGBYXSKOLAM-UHFFFAOYSA-N 5-bromo-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound OCC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1F XXSSGBYXSKOLAM-UHFFFAOYSA-N 0.000 claims description 2
- QIPKGNZZELMQAF-UHFFFAOYSA-N 5-bromo-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoroanilino)benzamide Chemical compound OCC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=CC=C1F QIPKGNZZELMQAF-UHFFFAOYSA-N 0.000 claims description 2
- GNQPYQRZLIRIAD-UHFFFAOYSA-N 5-bromo-n-cyclohexyl-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NC1CCCCC1 GNQPYQRZLIRIAD-UHFFFAOYSA-N 0.000 claims description 2
- VBFVICYZHVZQIF-UHFFFAOYSA-N 5-bromo-n-cyclopropyl-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NC1CC1 VBFVICYZHVZQIF-UHFFFAOYSA-N 0.000 claims description 2
- NKKKFJAWSPBXJY-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(1-hydroxypropan-2-yloxy)benzamide Chemical compound OCC(C)ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F NKKKFJAWSPBXJY-UHFFFAOYSA-N 0.000 claims description 2
- HJUQAPXWAOQWSL-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-3-phenoxypropoxy)benzamide Chemical compound C=1C=CC=CC=1OCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl HJUQAPXWAOQWSL-UHFFFAOYSA-N 0.000 claims description 2
- UERGDHKVDGCBAM-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl UERGDHKVDGCBAM-UHFFFAOYSA-N 0.000 claims description 2
- MKRVIYRPNNYISB-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl MKRVIYRPNNYISB-UHFFFAOYSA-N 0.000 claims description 2
- MBXXUKAZBOOXOL-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(O)=O MBXXUKAZBOOXOL-UHFFFAOYSA-N 0.000 claims description 2
- BBBDOQOTMWAZOP-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[[2-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound OCC1CC1CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F BBBDOQOTMWAZOP-UHFFFAOYSA-N 0.000 claims description 2
- FVMKNRIUORTHMN-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F FVMKNRIUORTHMN-UHFFFAOYSA-N 0.000 claims description 2
- DLRYQSUOLSMRML-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(2-methoxyethoxy)benzamide Chemical compound COCCONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1C DLRYQSUOLSMRML-UHFFFAOYSA-N 0.000 claims description 2
- MDHNYOSVEYIJOA-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(1-hydroxypropan-2-yloxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound OCC(C)ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1C MDHNYOSVEYIJOA-UHFFFAOYSA-N 0.000 claims description 2
- GQYWGPXEYKSXPM-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(2-hydroxy-3-phenoxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCC(O)COC1=CC=CC=C1 GQYWGPXEYKSXPM-UHFFFAOYSA-N 0.000 claims description 2
- DWNGMUSDLMQOSA-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(2-hydroxybutoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1C DWNGMUSDLMQOSA-UHFFFAOYSA-N 0.000 claims description 2
- DAHVEHSUBGUWGR-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(3-hydroxy-2,2-dimethylpropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCC(C)(C)CO DAHVEHSUBGUWGR-UHFFFAOYSA-N 0.000 claims description 2
- RCKXWJPGNUQSAX-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-hydroxy-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NO RCKXWJPGNUQSAX-UHFFFAOYSA-N 0.000 claims description 2
- UVQPYTNHXUMIMH-UHFFFAOYSA-N 5-chloro-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound OCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F UVQPYTNHXUMIMH-UHFFFAOYSA-N 0.000 claims description 2
- AFEDMNZRSBBDCZ-UHFFFAOYSA-N 5-chloro-n-(3,4-dihydroxybutoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCCC(O)CO AFEDMNZRSBBDCZ-UHFFFAOYSA-N 0.000 claims description 2
- FUISGEKSDHFZAN-UHFFFAOYSA-N 5-chloro-n-(cyclopropylmethoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound FC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCC1CC1 FUISGEKSDHFZAN-UHFFFAOYSA-N 0.000 claims description 2
- NYSBUFZXTTZARS-UHFFFAOYSA-N 5-chloro-n-(cyclopropylmethoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCC1CC1 NYSBUFZXTTZARS-UHFFFAOYSA-N 0.000 claims description 2
- UVQPYTNHXUMIMH-MRVPVSSYSA-N 5-chloro-n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound OC[C@@H](O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F UVQPYTNHXUMIMH-MRVPVSSYSA-N 0.000 claims description 2
- YPPGTJWMYLGECO-UHFFFAOYSA-N 5-chloro-n-cyclohexyl-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NC1CCCCC1 YPPGTJWMYLGECO-UHFFFAOYSA-N 0.000 claims description 2
- BNECLIPSPRXTNW-UHFFFAOYSA-N 5-fluoro-2-(4-iodo-2-methylanilino)-n-[(3-methylphenyl)methyl]benzamide Chemical compound CC1=CC=CC(CNC(=O)C=2C(=CC=C(F)C=2)NC=2C(=CC(I)=CC=2)C)=C1 BNECLIPSPRXTNW-UHFFFAOYSA-N 0.000 claims description 2
- PPBHPHGQDGGSHX-UHFFFAOYSA-N 5-fluoro-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(F)C=C1C(O)=O PPBHPHGQDGGSHX-UHFFFAOYSA-N 0.000 claims description 2
- YSXVOTVVUSIKNI-UHFFFAOYSA-N 5-fluoro-n-(2-hydroxyethyl)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(F)C=C1C(=O)NCCO YSXVOTVVUSIKNI-UHFFFAOYSA-N 0.000 claims description 2
- KOXXMRABYKWLII-UHFFFAOYSA-N 5-iodo-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(I)C=C1C(O)=O KOXXMRABYKWLII-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 229910003827 NRaRb Inorganic materials 0.000 claims description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Substances OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- GKWWBJHERNQSPO-UHFFFAOYSA-N n-(2,3-dihydroxypropoxy)-3,4,5-trifluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound OCC(O)CONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1F GKWWBJHERNQSPO-UHFFFAOYSA-N 0.000 claims description 2
- AIARPTGIJHULKY-UHFFFAOYSA-N n-(2,3-dihydroxypropoxy)-4-fluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound OCC(O)CONC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1F AIARPTGIJHULKY-UHFFFAOYSA-N 0.000 claims description 2
- RYOCQJVSICWPKA-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-(4-iodo-2-methylanilino)-5-nitrobenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NCCO RYOCQJVSICWPKA-UHFFFAOYSA-N 0.000 claims description 2
- JDQKKPHXLMZTFM-UHFFFAOYSA-N n-(2-hydroxyethyl)-5-iodo-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(I)C=C1C(=O)NCCO JDQKKPHXLMZTFM-UHFFFAOYSA-N 0.000 claims description 2
- HGXUEXUZCRYPLV-UHFFFAOYSA-N n-(cyclopropylmethoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC1CC1 HGXUEXUZCRYPLV-UHFFFAOYSA-N 0.000 claims description 2
- UESARFTYTCYCQK-UHFFFAOYSA-N n-(cyclopropylmethoxy)-4-fluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound C=1C=C(I)C=C(F)C=1NC1=CC(F)=CC=C1C(=O)NOCC1CC1 UESARFTYTCYCQK-UHFFFAOYSA-N 0.000 claims description 2
- MFTVPZWSFTVKDW-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CN(C)CCCNC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C MFTVPZWSFTVKDW-UHFFFAOYSA-N 0.000 claims description 2
- HHVULRUXZSEDQK-UHFFFAOYSA-N n-but-3-ynoxy-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCC#C HHVULRUXZSEDQK-UHFFFAOYSA-N 0.000 claims description 2
- ZTMPSQKWWVAXQV-UHFFFAOYSA-N n-cyclohexyl-5-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(F)C=C1C(=O)NC1CCCCC1 ZTMPSQKWWVAXQV-UHFFFAOYSA-N 0.000 claims description 2
- FKURQLBTBBUUAQ-UHFFFAOYSA-N n-cyclohexyl-5-iodo-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(I)C=C1C(=O)NC1CCCCC1 FKURQLBTBBUUAQ-UHFFFAOYSA-N 0.000 claims description 2
- NVABLGSLZIYASV-UHFFFAOYSA-N n-cyclopentyloxy-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOC1CCCC1 NVABLGSLZIYASV-UHFFFAOYSA-N 0.000 claims description 2
- ISERPJZNOJTETH-UHFFFAOYSA-N n-cyclopentyloxy-4-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NOC1CCCC1 ISERPJZNOJTETH-UHFFFAOYSA-N 0.000 claims description 2
- APDFSUINPPLQLM-UHFFFAOYSA-N n-cyclopropyl-5-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(F)C=C1C(=O)NC1CC1 APDFSUINPPLQLM-UHFFFAOYSA-N 0.000 claims description 2
- IVKQAKIJQNIBIO-UHFFFAOYSA-N n-hydroxy-2-(4-iodo-2-methylanilino)-4-nitrobenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC([N+]([O-])=O)=CC=C1C(=O)NO IVKQAKIJQNIBIO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052705 radium Inorganic materials 0.000 claims description 2
- 229910052701 rubidium Inorganic materials 0.000 claims description 2
- LWWPTYNMVLDNII-UHFFFAOYSA-M sodium;5-chloro-2-(4-iodo-2-methylanilino)benzoate Chemical compound [Na+].CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C([O-])=O LWWPTYNMVLDNII-UHFFFAOYSA-M 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 11
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 6
- AGEROJAJZRJBGM-UHFFFAOYSA-N n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=CC=C1 AGEROJAJZRJBGM-UHFFFAOYSA-N 0.000 claims 5
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 4
- KPHMJDFZXRMPJX-UHFFFAOYSA-N 2,3-difluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=CC(F)=C1F KPHMJDFZXRMPJX-UHFFFAOYSA-N 0.000 claims 1
- NYBPHFUZCDJFJD-UHFFFAOYSA-N 2-(2,3-dihydroxypropoxy)-3,4-difluorobenzamide Chemical compound NC(=O)C1=CC=C(F)C(F)=C1OCC(O)CO NYBPHFUZCDJFJD-UHFFFAOYSA-N 0.000 claims 1
- XYYUOXLXTADKMW-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-4-fluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1Br XYYUOXLXTADKMW-UHFFFAOYSA-N 0.000 claims 1
- NGNWYDBHBYZNEJ-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-5-chloro-n-(cyclopropylmethoxy)-3,4-difluorobenzamide;2-(2-bromo-4-iodoanilino)-n-(cyclopropylmethoxy)-4-nitrobenzamide Chemical compound C=1C=C(I)C=C(Br)C=1NC1=CC([N+](=O)[O-])=CC=C1C(=O)NOCC1CC1.C=1C=C(I)C=C(Br)C=1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCC1CC1 NGNWYDBHBYZNEJ-UHFFFAOYSA-N 0.000 claims 1
- NMGPTKSLPIARAK-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-n-hydroxy-4-nitrobenzamide Chemical compound ONC(=O)C1=CC=C([N+]([O-])=O)C=C1NC1=CC=C(I)C=C1Br NMGPTKSLPIARAK-UHFFFAOYSA-N 0.000 claims 1
- BZSLAYDTMNXEOY-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-4-fluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1Cl BZSLAYDTMNXEOY-UHFFFAOYSA-N 0.000 claims 1
- NITWKACUMSHLOB-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(2-phenoxyethoxy)benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCOC1=CC=CC=C1 NITWKACUMSHLOB-UHFFFAOYSA-N 0.000 claims 1
- JGKIBUDEERWECG-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(2-thiophen-2-ylethyl)benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NCCC1=CC=CS1 JGKIBUDEERWECG-UHFFFAOYSA-N 0.000 claims 1
- MCDZEUZYVPGCQV-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-[3-(3-fluorophenyl)prop-2-ynoxy]benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC#CC1=CC=CC(F)=C1 MCDZEUZYVPGCQV-UHFFFAOYSA-N 0.000 claims 1
- SLODYXNZAINLFD-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-but-2-enoxy-3,4-difluorobenzamide Chemical compound CC=CCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1C SLODYXNZAINLFD-UHFFFAOYSA-N 0.000 claims 1
- LWZBCTIJTITZBA-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-but-3-ynoxy-3,4-difluorobenzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCC#C LWZBCTIJTITZBA-UHFFFAOYSA-N 0.000 claims 1
- LUVODTHAYCCRJL-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-cyclobutyloxy-3,4-difluorobenzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOC1CCC1 LUVODTHAYCCRJL-UHFFFAOYSA-N 0.000 claims 1
- YDBKFXZLWHEYBN-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-ethoxy-3,4-difluorobenzamide Chemical compound CCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1C YDBKFXZLWHEYBN-UHFFFAOYSA-N 0.000 claims 1
- XLTVXGORWXCJNJ-UHFFFAOYSA-N 2-(4-iodoanilino)-5-methoxybenzoic acid Chemical compound OC(=O)C1=CC(OC)=CC=C1NC1=CC=C(I)C=C1 XLTVXGORWXCJNJ-UHFFFAOYSA-N 0.000 claims 1
- VYMOPINAHSCMIG-UHFFFAOYSA-N 2-(furan-3-ylmethoxy)benzamide Chemical compound NC(=O)C1=CC=CC=C1OCC1=COC=C1 VYMOPINAHSCMIG-UHFFFAOYSA-N 0.000 claims 1
- FFWHBZSAYAWKNK-UHFFFAOYSA-N 2-(pyridin-4-ylmethyl)benzamide Chemical compound NC(=O)C1=CC=CC=C1CC1=CC=NC=C1 FFWHBZSAYAWKNK-UHFFFAOYSA-N 0.000 claims 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- XXUNIGZDNWWYED-UHFFFAOYSA-N 2-methylbenzamide Chemical compound CC1=CC=CC=C1C(N)=O XXUNIGZDNWWYED-UHFFFAOYSA-N 0.000 claims 1
- BTHLVVULQLRTBK-UHFFFAOYSA-N 2-propan-2-yloxybenzamide Chemical compound CC(C)OC1=CC=CC=C1C(N)=O BTHLVVULQLRTBK-UHFFFAOYSA-N 0.000 claims 1
- RTXVXAWCWOSOKY-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F RTXVXAWCWOSOKY-UHFFFAOYSA-N 0.000 claims 1
- IPVITVKNQFEBEA-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F IPVITVKNQFEBEA-UHFFFAOYSA-N 0.000 claims 1
- ABJLISRFDAOKMP-UHFFFAOYSA-N 3,4-difluoro-n-(3-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCCO ABJLISRFDAOKMP-UHFFFAOYSA-N 0.000 claims 1
- 125000001137 3-hydroxypropoxy group Chemical group [H]OC([H])([H])C([H])([H])C([H])([H])O* 0.000 claims 1
- OEDQBUOUDGINPB-UHFFFAOYSA-N 4-fluoro-2-(2-fluoro-4-iodoanilino)-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1F OEDQBUOUDGINPB-UHFFFAOYSA-N 0.000 claims 1
- VNDHYTGVCGVETQ-UHFFFAOYSA-N 4-fluorobenzamide Chemical compound NC(=O)C1=CC=C(F)C=C1 VNDHYTGVCGVETQ-UHFFFAOYSA-N 0.000 claims 1
- OOENECXPJLFZNY-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl OOENECXPJLFZNY-UHFFFAOYSA-N 0.000 claims 1
- VJNZMSLGVUSPCF-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-n-(cyclopropylmethoxy)-3,4-difluorobenzamide Chemical compound C1CC1CONC(=O)C=1C=C(Br)C(F)=C(F)C=1NC1=CC=C(I)C=C1Cl VJNZMSLGVUSPCF-UHFFFAOYSA-N 0.000 claims 1
- KLWVQBQQPZPQCK-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-n-[2-(dimethylamino)ethoxy]-3,4-difluorobenzamide Chemical compound CN(C)CCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl KLWVQBQQPZPQCK-UHFFFAOYSA-N 0.000 claims 1
- QTDDKGUPEPKNIP-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(2-piperidin-1-ylethyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NCCN1CCCCC1 QTDDKGUPEPKNIP-UHFFFAOYSA-N 0.000 claims 1
- ZXCWXANNFFPFMA-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-[3-(3-methoxyphenyl)prop-2-ynoxy]benzamide Chemical compound COC1=CC=CC(C#CCONC(=O)C=2C(=C(F)C(F)=C(Br)C=2)NC=2C(=CC(I)=CC=2)C)=C1 ZXCWXANNFFPFMA-UHFFFAOYSA-N 0.000 claims 1
- RMQCMEKPFHQYKN-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(3-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCCCO RMQCMEKPFHQYKN-UHFFFAOYSA-N 0.000 claims 1
- IPJAGDMRFVGHCN-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-hydroxy-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NO IPJAGDMRFVGHCN-UHFFFAOYSA-N 0.000 claims 1
- IBZPDAZZGTZKNJ-UHFFFAOYSA-N 5-bromo-n-[2-(dimethylamino)propoxy]-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CN(C)C(C)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C IBZPDAZZGTZKNJ-UHFFFAOYSA-N 0.000 claims 1
- ZQOIUOMBQVPIAV-UHFFFAOYSA-N 5-bromo-n-but-2-enoxy-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC=CCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C ZQOIUOMBQVPIAV-UHFFFAOYSA-N 0.000 claims 1
- ORDKSJQARZCGBK-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)-n-methoxybenzamide Chemical compound CONC(=O)C1=CC(Cl)=CC=C1NC1=CC=C(I)C=C1C ORDKSJQARZCGBK-UHFFFAOYSA-N 0.000 claims 1
- HHLZFIBFGYVDRZ-UHFFFAOYSA-N 5-chloro-n-hydroxy-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NO HHLZFIBFGYVDRZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 1
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 1
- HCLTXIJMXQOFLI-UHFFFAOYSA-N IC1=CC(=C(C=C1)NC1=C(C(=O)NCC2=CC=C(C=C2)S(N)(=O)=O)C=CC=C1)C Chemical compound IC1=CC(=C(C=C1)NC1=C(C(=O)NCC2=CC=C(C=C2)S(N)(=O)=O)C=CC=C1)C HCLTXIJMXQOFLI-UHFFFAOYSA-N 0.000 claims 1
- AYAZZQJGORVQSN-UHFFFAOYSA-N N,N-dimethylbenzamide Chemical compound CN(C(C1=CC=CC=C1)=O)C.CN(C(C1=CC=CC=C1)=O)C AYAZZQJGORVQSN-UHFFFAOYSA-N 0.000 claims 1
- JRRRPRQQGNMODT-UHFFFAOYSA-N N-(2-hydroxypropoxy)benzamide Chemical compound C1=CC=CC(=C1)C(=O)NOCC(O)C JRRRPRQQGNMODT-UHFFFAOYSA-N 0.000 claims 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- TYHIZTJRCMNBDH-UHFFFAOYSA-N n-(cyclopropylmethoxy)-2-(2-fluoro-4-iodoanilino)-4-nitrobenzamide Chemical compound C=1C=C(I)C=C(F)C=1NC1=CC([N+](=O)[O-])=CC=C1C(=O)NOCC1CC1 TYHIZTJRCMNBDH-UHFFFAOYSA-N 0.000 claims 1
- RJPCFXZBKMJDCK-UHFFFAOYSA-N n-(cyclopropylmethoxy)-2-(4-iodo-2-methylanilino)-4-nitrobenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC([N+]([O-])=O)=CC=C1C(=O)NOCC1CC1 RJPCFXZBKMJDCK-UHFFFAOYSA-N 0.000 claims 1
- PNTKSRDALUNXIE-UHFFFAOYSA-N n-(cyclopropylmethoxy)-3,4,5-trifluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound C=1C=C(I)C=C(F)C=1NC=1C(F)=C(F)C(F)=CC=1C(=O)NOCC1CC1 PNTKSRDALUNXIE-UHFFFAOYSA-N 0.000 claims 1
- ZQRHTXJWJRVYGA-UHFFFAOYSA-N n-(cyclopropylmethoxy)-4-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NOCC1CC1 ZQRHTXJWJRVYGA-UHFFFAOYSA-N 0.000 claims 1
- ASOKITCGBKGOAH-UHFFFAOYSA-N n-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound O1C(C)(C)OCC1CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F ASOKITCGBKGOAH-UHFFFAOYSA-N 0.000 claims 1
- ZHKTXUBWPSVDAP-UHFFFAOYSA-N n-cyclohexyl-2-(4-iodo-2-methylanilino)-5-nitrobenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NC1CCCCC1 ZHKTXUBWPSVDAP-UHFFFAOYSA-N 0.000 claims 1
- 102000004890 Interleukin-8 Human genes 0.000 description 83
- 108090001007 Interleukin-8 Proteins 0.000 description 83
- 230000035605 chemotaxis Effects 0.000 description 42
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- 230000004913 activation Effects 0.000 description 24
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 22
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- 239000002585 base Substances 0.000 description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 230000037361 pathway Effects 0.000 description 18
- 108091007960 PI3Ks Proteins 0.000 description 16
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 16
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 16
- 235000010233 benzoic acid Nutrition 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 15
- 241000283973 Oryctolagus cuniculus Species 0.000 description 15
- 238000003556 assay Methods 0.000 description 15
- 102000043136 MAP kinase family Human genes 0.000 description 14
- 108091054455 MAP kinase family Proteins 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 238000001727 in vivo Methods 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 13
- 238000000338 in vitro Methods 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000003112 inhibitor Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 10
- 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000007115 recruitment Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 229940054066 benzamide antipsychotics Drugs 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000005859 coupling reaction Methods 0.000 description 9
- 210000000224 granular leucocyte Anatomy 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 239000003981 vehicle Substances 0.000 description 9
- 102000019034 Chemokines Human genes 0.000 description 8
- 108010012236 Chemokines Proteins 0.000 description 8
- 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 150000003936 benzamides Chemical class 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000007822 coupling agent Substances 0.000 description 8
- 231100000673 dose–response relationship Toxicity 0.000 description 8
- 229940126062 Compound A Drugs 0.000 description 7
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 7
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 125000001153 fluoro group Chemical group F* 0.000 description 7
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 7
- 229940096397 interleukin-8 Drugs 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 238000001262 western blot Methods 0.000 description 7
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- ZWJINEZUASEZBH-UHFFFAOYSA-N fenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC=C1 ZWJINEZUASEZBH-UHFFFAOYSA-N 0.000 description 6
- 102000010681 interleukin-8 receptors Human genes 0.000 description 6
- 108010038415 interleukin-8 receptors Proteins 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical group CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 5
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 5
- 101710146526 Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 description 5
- GKQLYSROISKDLL-UHFFFAOYSA-N EEDQ Chemical compound C1=CC=C2N(C(=O)OCC)C(OCC)C=CC2=C1 GKQLYSROISKDLL-UHFFFAOYSA-N 0.000 description 5
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 150000001559 benzoic acids Chemical class 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 238000005897 peptide coupling reaction Methods 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 238000010561 standard procedure Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 229910014033 C-OH Inorganic materials 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229910014570 C—OH Inorganic materials 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 230000005723 MEK inhibition Effects 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical group C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 4
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 4
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 239000002516 radical scavenger Substances 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 125000000547 substituted alkyl group Chemical group 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- IQHSSYROJYPFDV-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC(Cl)=C(Br)C(Cl)=C1 IQHSSYROJYPFDV-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 101000876610 Dictyostelium discoideum Extracellular signal-regulated kinase 2 Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 108040008097 MAP kinase activity proteins Proteins 0.000 description 3
- 102000019149 MAP kinase activity proteins Human genes 0.000 description 3
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 125000005262 alkoxyamine group Chemical group 0.000 description 3
- 125000004103 aminoalkyl group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 230000003399 chemotactic effect Effects 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 3
- 125000005027 hydroxyaryl group Chemical group 0.000 description 3
- 150000002443 hydroxylamines Chemical class 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000002346 iodo group Chemical group I* 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 229940068917 polyethylene glycols Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007909 solid dosage form Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WZPWTXZSQHIABL-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenyl) benzoate Chemical class FC1=C(F)C(F)=C(F)C(F)=C1OC(=O)C1=CC=CC=C1 WZPWTXZSQHIABL-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- QFWCYNPOPKQOKV-UHFFFAOYSA-N 2-(2-amino-3-methoxyphenyl)chromen-4-one Chemical compound COC1=CC=CC(C=2OC3=CC=CC=C3C(=O)C=2)=C1N QFWCYNPOPKQOKV-UHFFFAOYSA-N 0.000 description 2
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 2
- WRIPZDWCGAIYEF-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)-5-nitro-n-[(4-sulfamoylphenyl)methyl]benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NCC1=CC=C(S(N)(=O)=O)C=C1 WRIPZDWCGAIYEF-UHFFFAOYSA-N 0.000 description 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 2
- CKIRZXDWDRUDIR-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F CKIRZXDWDRUDIR-UHFFFAOYSA-N 0.000 description 2
- JXQALZUQMVXFAC-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[2-(methylamino)ethoxy]benzamide Chemical compound CNCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F JXQALZUQMVXFAC-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- VLVCDUSVTXIWGW-UHFFFAOYSA-N 4-iodoaniline Chemical compound NC1=CC=C(I)C=C1 VLVCDUSVTXIWGW-UHFFFAOYSA-N 0.000 description 2
- DSFQOJWTJQNGSU-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)-n-[(4-sulfamoylphenyl)methyl]benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NCC1=CC=C(S(N)(=O)=O)C=C1 DSFQOJWTJQNGSU-UHFFFAOYSA-N 0.000 description 2
- ASLGKYRJGJLPAE-MRVPVSSYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluorobenzamide Chemical compound OC[C@@H](O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl ASLGKYRJGJLPAE-MRVPVSSYSA-N 0.000 description 2
- ASLGKYRJGJLPAE-QMMMGPOBSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-n-[(2s)-2,3-dihydroxypropoxy]-3,4-difluorobenzamide Chemical compound OC[C@H](O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl ASLGKYRJGJLPAE-QMMMGPOBSA-N 0.000 description 2
- DAVWVMNCZOSIBH-UHFFFAOYSA-N 5-chloro-n-(1,3-dihydroxypropan-2-yloxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound OCC(CO)ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F DAVWVMNCZOSIBH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 2
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241000206672 Gelidium Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108010018951 Interleukin-8B Receptors Proteins 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 229940121849 Mitotic inhibitor Drugs 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 2
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 2
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 2
- 101710141955 RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 2
- 239000012083 RIPA buffer Substances 0.000 description 2
- 240000005608 Ranunculus bulbosus Species 0.000 description 2
- 235000000903 Ranunculus bulbosus Nutrition 0.000 description 2
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 2
- RROBIDXNTUAHFW-UHFFFAOYSA-N benzotriazol-1-yloxy-tris(dimethylamino)phosphanium Chemical compound C1=CC=C2N(O[P+](N(C)C)(N(C)C)N(C)C)N=NC2=C1 RROBIDXNTUAHFW-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 238000000423 cell based assay Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000002975 chemoattractant Substances 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- 229960002986 dinoprostone Drugs 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 125000005020 hydroxyalkenyl group Chemical group 0.000 description 2
- 125000005016 hydroxyalkynyl group Chemical group 0.000 description 2
- 125000005350 hydroxycycloalkyl group Chemical group 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 239000003701 inert diluent Substances 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000000021 kinase assay Methods 0.000 description 2
- 238000011813 knockout mouse model Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000008297 liquid dosage form Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000002757 morpholinyl group Chemical group 0.000 description 2
- AEAMPCCYDKGXCC-UHFFFAOYSA-N n-(1,3-dihydroxypropan-2-yloxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound OCC(CO)ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F AEAMPCCYDKGXCC-UHFFFAOYSA-N 0.000 description 2
- IGVMHOOQGPQIMZ-UHFFFAOYSA-N n-(2-anilinoethoxy)-2-(2-chloro-4-iodoanilino)-3,4-difluorobenzamide Chemical compound C=1C=C(I)C=C(Cl)C=1NC1=C(F)C(F)=CC=C1C(=O)NOCCNC1=CC=CC=C1 IGVMHOOQGPQIMZ-UHFFFAOYSA-N 0.000 description 2
- IDXFBAOJNKCQTB-UHFFFAOYSA-N n-cyclopropyl-2-(4-iodo-2-methylanilino)-5-nitrobenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NC1CC1 IDXFBAOJNKCQTB-UHFFFAOYSA-N 0.000 description 2
- 230000030505 negative regulation of chemotaxis Effects 0.000 description 2
- 125000005060 octahydroindolyl group Chemical group N1(CCC2CCCCC12)* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- 239000003880 polar aprotic solvent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 102000009929 raf Kinases Human genes 0.000 description 2
- 108010077182 raf Kinases Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000019254 respiratory burst Effects 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 230000007727 signaling mechanism Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- 125000003554 tetrahydropyrrolyl group Chemical group 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical class CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- XGOGYOBKQVLGAY-UHFFFAOYSA-N 2,3,4-trifluorobenzamide Chemical compound NC(=O)C1=CC=C(F)C(F)=C1F XGOGYOBKQVLGAY-UHFFFAOYSA-N 0.000 description 1
- BPORPGYWYCZFIQ-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(F)C=C1F BPORPGYWYCZFIQ-UHFFFAOYSA-N 0.000 description 1
- BUCUZFYTODLSLK-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxy-3-methoxypropoxy)benzamide Chemical compound COCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(F)C=C1F BUCUZFYTODLSLK-UHFFFAOYSA-N 0.000 description 1
- YQHATYMDYRAGRC-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(F)C=C1F YQHATYMDYRAGRC-UHFFFAOYSA-N 0.000 description 1
- CMEINIFNSBBEPU-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(F)C=C1F CMEINIFNSBBEPU-UHFFFAOYSA-N 0.000 description 1
- SDNFEPSSQCCTDP-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-(3,3,3-trifluoro-2-hydroxypropoxy)benzamide Chemical compound FC(F)(F)C(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(F)C=C1F SDNFEPSSQCCTDP-UHFFFAOYSA-N 0.000 description 1
- AJBLOQYWEWENKM-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-[[1-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound C=1C=C(F)C(F)=C(NC=2C(=CC(F)=CC=2)F)C=1C(=O)NOCC1(CO)CC1 AJBLOQYWEWENKM-UHFFFAOYSA-N 0.000 description 1
- HTAQKRHMBXAWBW-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-3,4-difluoro-n-[[2-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound OCC1CC1CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(F)C=C1F HTAQKRHMBXAWBW-UHFFFAOYSA-N 0.000 description 1
- QMALWSSCPZJMOO-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NC1=CC=C(I)C=C1Br QMALWSSCPZJMOO-UHFFFAOYSA-N 0.000 description 1
- BWOZEHCSZGOGER-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-n-(cyclopropylmethoxy)-3,4,5-trifluorobenzamide Chemical compound C=1C=C(I)C=C(Br)C=1NC=1C(F)=C(F)C(F)=CC=1C(=O)NOCC1CC1 BWOZEHCSZGOGER-UHFFFAOYSA-N 0.000 description 1
- RDTSNRQFNRNSCU-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-n-(cyclopropylmethoxy)-3,4-difluorobenzamide Chemical compound C=1C=C(I)C=C(Br)C=1NC1=C(F)C(F)=CC=C1C(=O)NOCC1CC1 RDTSNRQFNRNSCU-UHFFFAOYSA-N 0.000 description 1
- LZRKJVJJXDFWLG-UHFFFAOYSA-N 2-(2-bromo-4-iodoanilino)-n-(cyclopropylmethoxy)-4-fluorobenzamide Chemical compound C=1C=C(I)C=C(Br)C=1NC1=CC(F)=CC=C1C(=O)NOCC1CC1 LZRKJVJJXDFWLG-UHFFFAOYSA-N 0.000 description 1
- PYMZEKGOVJOENJ-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-(1-hydroxypropan-2-yloxy)benzamide Chemical compound OCC(C)ONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl PYMZEKGOVJOENJ-UHFFFAOYSA-N 0.000 description 1
- ZCSHJJHAFSSWTQ-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-(2-hydroxy-3-phenoxypropoxy)benzamide Chemical compound C=1C=CC=CC=1OCC(O)CONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl ZCSHJJHAFSSWTQ-UHFFFAOYSA-N 0.000 description 1
- XBBDXCSMZAFUCG-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl XBBDXCSMZAFUCG-UHFFFAOYSA-N 0.000 description 1
- GAXAWGNBLRJXOG-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4,5-trifluoro-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl GAXAWGNBLRJXOG-UHFFFAOYSA-N 0.000 description 1
- VEFHUCQYLJVXTF-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl VEFHUCQYLJVXTF-UHFFFAOYSA-N 0.000 description 1
- ZDTUJTKFWCTQTA-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl ZDTUJTKFWCTQTA-UHFFFAOYSA-N 0.000 description 1
- YMUMVSKMVSKYGO-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl YMUMVSKMVSKYGO-UHFFFAOYSA-N 0.000 description 1
- IAONLJBXSDDXBK-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-methoxyethoxy)benzamide Chemical compound COCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl IAONLJBXSDDXBK-UHFFFAOYSA-N 0.000 description 1
- JJWZQOCFYVYNBJ-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(3-hydroxypropoxy)benzamide Chemical compound OCCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl JJWZQOCFYVYNBJ-UHFFFAOYSA-N 0.000 description 1
- HSDWPBDPQQYPSX-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-[2-(2-methoxyethoxy)ethoxy]benzamide Chemical compound COCCOCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl HSDWPBDPQQYPSX-UHFFFAOYSA-N 0.000 description 1
- ZEZXICVAWOUQSB-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-4-fluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1Cl ZEZXICVAWOUQSB-UHFFFAOYSA-N 0.000 description 1
- OLTJOKGXRQIKDW-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-4-fluoro-n-(3-hydroxypropoxy)benzamide Chemical compound OCCCONC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1Cl OLTJOKGXRQIKDW-UHFFFAOYSA-N 0.000 description 1
- FCADPEDUULETPK-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-(2,3-dihydroxypropoxy)-3,4-difluorobenzamide Chemical compound OCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl FCADPEDUULETPK-UHFFFAOYSA-N 0.000 description 1
- IIOZVFAQPNCVDB-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-(2-ethenoxyethoxy)-3,4,5-trifluorobenzamide Chemical compound FC1=C(F)C(F)=CC(C(=O)NOCCOC=C)=C1NC1=CC=C(I)C=C1Cl IIOZVFAQPNCVDB-UHFFFAOYSA-N 0.000 description 1
- CGKDFNXLPSAJDR-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-(2-ethenoxyethoxy)-3,4-difluorobenzamide Chemical compound FC1=CC=C(C(=O)NOCCOC=C)C(NC=2C(=CC(I)=CC=2)Cl)=C1F CGKDFNXLPSAJDR-UHFFFAOYSA-N 0.000 description 1
- KMOJVHZDHFUOOX-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-(3,4-dihydroxybutoxy)-3,4,5-trifluorobenzamide Chemical compound OCC(O)CCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl KMOJVHZDHFUOOX-UHFFFAOYSA-N 0.000 description 1
- IZMLLDXEDRFLQB-UHFFFAOYSA-N 2-(2-chloro-4-iodoanilino)-n-(3,4-dihydroxybutoxy)-3,4-difluorobenzamide Chemical compound OCC(O)CCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl IZMLLDXEDRFLQB-UHFFFAOYSA-N 0.000 description 1
- BQQMUASDAHOKDU-UHFFFAOYSA-N 2-(2-ethyl-4-iodoanilino)-n-(2-hydroxyethyl)-5-nitrobenzamide Chemical compound CCC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NCCO BQQMUASDAHOKDU-UHFFFAOYSA-N 0.000 description 1
- NTFNBJZNPJLWEH-UHFFFAOYSA-N 2-(4-bromo-2-fluoroanilino)-3,4-difluoro-n-(2-hydroxy-3-methoxypropoxy)benzamide Chemical compound COCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1F NTFNBJZNPJLWEH-UHFFFAOYSA-N 0.000 description 1
- NDJKNRAGHSTRCO-UHFFFAOYSA-N 2-(4-bromo-2-fluoroanilino)-3,4-difluoro-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1F NDJKNRAGHSTRCO-UHFFFAOYSA-N 0.000 description 1
- MCPHGMKRTXFBEQ-UHFFFAOYSA-N 2-(4-bromo-2-fluoroanilino)-4,5-difluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(F)=C(F)C=C1NC1=CC=C(Br)C=C1F MCPHGMKRTXFBEQ-UHFFFAOYSA-N 0.000 description 1
- UHJODXSWHNJGET-UHFFFAOYSA-N 2-(4-bromo-2-fluoroanilino)-n-(2,3-dihydroxypropoxy)-3,4-difluorobenzamide Chemical compound OCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1F UHJODXSWHNJGET-UHFFFAOYSA-N 0.000 description 1
- UHJODXSWHNJGET-SECBINFHSA-N 2-(4-bromo-2-fluoroanilino)-n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluorobenzamide Chemical compound OC[C@@H](O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1F UHJODXSWHNJGET-SECBINFHSA-N 0.000 description 1
- UDMYBSQMRDBEIC-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(2-hydroxyethyl)benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NCCO UDMYBSQMRDBEIC-UHFFFAOYSA-N 0.000 description 1
- QBTVPUBNRWFMGL-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(2-morpholin-4-ylethyl)benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NCCN1CCOCC1 QBTVPUBNRWFMGL-UHFFFAOYSA-N 0.000 description 1
- PFLMFENBMHGHFI-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(2-phenylethyl)benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NCCC1=CC=CC=C1 PFLMFENBMHGHFI-UHFFFAOYSA-N 0.000 description 1
- DLCASGFAOPGKAH-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(3-phenylprop-2-ynoxy)benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC#CC1=CC=CC=C1 DLCASGFAOPGKAH-UHFFFAOYSA-N 0.000 description 1
- YDOWUWRHGYWZHT-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(furan-3-ylmethoxy)benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC1=COC=C1 YDOWUWRHGYWZHT-UHFFFAOYSA-N 0.000 description 1
- FSCLSXYRUIVDGC-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluoro-n-(pyridin-4-ylmethyl)benzamide Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NCC1=CC=NC=C1 FSCLSXYRUIVDGC-UHFFFAOYSA-N 0.000 description 1
- OKAIUFBLOQNKIS-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-3,4-difluorobenzoic acid Chemical compound CC1=CC(Br)=CC=C1NC1=C(F)C(F)=CC=C1C(O)=O OKAIUFBLOQNKIS-UHFFFAOYSA-N 0.000 description 1
- DFYRJMXCUCOACA-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-4-fluorobenzoic acid Chemical compound CC1=CC(Br)=CC=C1NC1=CC(F)=CC=C1C(O)=O DFYRJMXCUCOACA-UHFFFAOYSA-N 0.000 description 1
- RASWBMJSCOCCOP-UHFFFAOYSA-N 2-(4-bromo-2-methylanilino)-n-[3-(dimethylamino)propyl]-3,4-difluorobenzamide Chemical compound CN(C)CCCNC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Br)C=C1C RASWBMJSCOCCOP-UHFFFAOYSA-N 0.000 description 1
- XCQADHKRYSKJOW-UHFFFAOYSA-N 2-(4-chloro-2-fluoroanilino)-3,4-difluoro-n-(2-hydroxy-3-methoxypropoxy)benzamide Chemical compound COCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Cl)C=C1F XCQADHKRYSKJOW-UHFFFAOYSA-N 0.000 description 1
- PUJBAKCTNFPEDJ-UHFFFAOYSA-N 2-(4-chloro-2-fluoroanilino)-3,4-difluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Cl)C=C1F PUJBAKCTNFPEDJ-UHFFFAOYSA-N 0.000 description 1
- PJMYVBPGLLGRFC-UHFFFAOYSA-N 2-(4-chloro-2-fluoroanilino)-3,4-difluoro-n-(3,3,3-trifluoro-2-hydroxypropoxy)benzamide Chemical compound FC(F)(F)C(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Cl)C=C1F PJMYVBPGLLGRFC-UHFFFAOYSA-N 0.000 description 1
- GAWADLAPZHGLPK-UHFFFAOYSA-N 2-(4-chloro-2-fluoroanilino)-3,4-difluoro-n-[[1-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound C=1C=C(F)C(F)=C(NC=2C(=CC(Cl)=CC=2)F)C=1C(=O)NOCC1(CO)CC1 GAWADLAPZHGLPK-UHFFFAOYSA-N 0.000 description 1
- DYCWDSFZFWCWLG-UHFFFAOYSA-N 2-(4-chloro-2-fluoroanilino)-3,4-difluoro-n-[[2-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound OCC1CC1CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(Cl)C=C1F DYCWDSFZFWCWLG-UHFFFAOYSA-N 0.000 description 1
- IPJKPORKWBURKZ-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)-4-nitrobenzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC([N+]([O-])=O)=CC=C1C(O)=O IPJKPORKWBURKZ-UHFFFAOYSA-N 0.000 description 1
- XVLPEYUVEHKUBW-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)-5-nitro-n-(2-piperidin-1-ylethyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NCCN1CCCCC1 XVLPEYUVEHKUBW-UHFFFAOYSA-N 0.000 description 1
- OLAJIJDQDNHPHA-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)-5-nitro-n-(3-piperidin-1-ylpropyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NCCCN1CCCCC1 OLAJIJDQDNHPHA-UHFFFAOYSA-N 0.000 description 1
- BJULGELJDWFRAX-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)-5-nitro-n-phenylmethoxybenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NOCC1=CC=CC=C1 BJULGELJDWFRAX-UHFFFAOYSA-N 0.000 description 1
- KLYXRBOQQVDCRR-UHFFFAOYSA-N 2-(4-iodo-2-methylanilino)-n-[(3-methylphenyl)methyl]-5-nitrobenzamide Chemical compound CC1=CC=CC(CNC(=O)C=2C(=CC=C(C=2)[N+]([O-])=O)NC=2C(=CC(I)=CC=2)C)=C1 KLYXRBOQQVDCRR-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- UDMKHKWSHSTUAD-UHFFFAOYSA-N 2-[[3,4,5-trifluoro-2-(4-iodo-2-methylanilino)benzoyl]amino]oxyethyl acetate Chemical compound CC(=O)OCCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1C UDMKHKWSHSTUAD-UHFFFAOYSA-N 0.000 description 1
- VXBGETLMHVNAMH-UHFFFAOYSA-N 2-[[5-chloro-2-(4-iodo-2-methylanilino)benzoyl]amino]acetic acid Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NCC(O)=O VXBGETLMHVNAMH-UHFFFAOYSA-N 0.000 description 1
- VVTCLTONLVZMDI-UHFFFAOYSA-N 2-anilino-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC=CC=C1NC1=CC=CC=C1 VVTCLTONLVZMDI-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- TVXWDBIJYZFGCG-UHFFFAOYSA-N 3,4,5-trifluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1F TVXWDBIJYZFGCG-UHFFFAOYSA-N 0.000 description 1
- JMBKUZIAOYNCDL-UHFFFAOYSA-N 3,4,5-trifluoro-2-(2-fluoro-4-iodoanilino)-n-(3,3,3-trifluoro-2-hydroxypropoxy)benzamide Chemical compound FC(F)(F)C(O)CONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1F JMBKUZIAOYNCDL-UHFFFAOYSA-N 0.000 description 1
- VPWVQHKFASDRES-UHFFFAOYSA-N 3,4,5-trifluoro-2-(2-fluoro-4-iodoanilino)-n-[[1-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound C=1C(F)=C(F)C(F)=C(NC=2C(=CC(I)=CC=2)F)C=1C(=O)NOCC1(CO)CC1 VPWVQHKFASDRES-UHFFFAOYSA-N 0.000 description 1
- CTCSFDWFHRBBJN-UHFFFAOYSA-N 3,4,5-trifluoro-2-(4-iodo-2-methylanilino)-n-(2-methoxyethoxy)benzamide Chemical compound COCCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1C CTCSFDWFHRBBJN-UHFFFAOYSA-N 0.000 description 1
- PYNVLZULWJUAJF-UHFFFAOYSA-N 3,4,5-trifluoro-2-(4-iodo-2-methylanilino)-n-[2-(2-methoxyethoxy)ethoxy]benzamide Chemical compound COCCOCCONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1C PYNVLZULWJUAJF-UHFFFAOYSA-N 0.000 description 1
- IKYHHUKKYADHCL-UHFFFAOYSA-N 3,4,5-trifluoro-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(O)=O IKYHHUKKYADHCL-UHFFFAOYSA-N 0.000 description 1
- GKNHASWNDVZWMC-UHFFFAOYSA-N 3,4,5-trifluoro-n-(2-hydroxy-2-methylpropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(=O)NOCC(C)(C)O GKNHASWNDVZWMC-UHFFFAOYSA-N 0.000 description 1
- COMKKJQESQABKZ-UHFFFAOYSA-N 3,4,5-trifluoro-n-(2-hydroxy-3-morpholin-4-ylpropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(=O)NOCC(O)CN1CCOCC1 COMKKJQESQABKZ-UHFFFAOYSA-N 0.000 description 1
- ZSUYOTZRXQOCRA-UHFFFAOYSA-N 3,4,5-trifluoro-n-(2-hydroxyethoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(=O)NOCCO ZSUYOTZRXQOCRA-UHFFFAOYSA-N 0.000 description 1
- DXNFXTNRYADQAZ-UHFFFAOYSA-N 3,4,5-trifluoro-n-(2-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC(O)CONC(=O)C1=CC(F)=C(F)C(F)=C1NC1=CC=C(I)C=C1C DXNFXTNRYADQAZ-UHFFFAOYSA-N 0.000 description 1
- CPRVRALKKBRIQE-UHFFFAOYSA-N 3,4,5-trifluoro-n-(3-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(=O)NOCCCO CPRVRALKKBRIQE-UHFFFAOYSA-N 0.000 description 1
- HIMTUIUWQDFWDV-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(1-hydroxy-2-methylpropan-2-yl)oxybenzamide Chemical compound OCC(C)(C)ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F HIMTUIUWQDFWDV-UHFFFAOYSA-N 0.000 description 1
- RQEXQLOMGJFXLO-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxy-3-morpholin-4-ylpropoxy)benzamide Chemical compound C1COCCN1CC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F RQEXQLOMGJFXLO-UHFFFAOYSA-N 0.000 description 1
- GQAZGSHVSAGDOJ-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F GQAZGSHVSAGDOJ-UHFFFAOYSA-N 0.000 description 1
- VNANPXLTGIUOAE-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F VNANPXLTGIUOAE-UHFFFAOYSA-N 0.000 description 1
- HEQVJXNKPBCCSR-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(3-hydroxy-2,2-dimethylpropoxy)benzamide Chemical compound OCC(C)(C)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F HEQVJXNKPBCCSR-UHFFFAOYSA-N 0.000 description 1
- GXQRYUHJCWWYIP-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(4-hydroxybutoxy)benzamide Chemical compound OCCCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F GXQRYUHJCWWYIP-UHFFFAOYSA-N 0.000 description 1
- FSQFMRBMEQDTGM-SNVBAGLBSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[(2r)-3-hydroxy-2-(methylamino)propoxy]benzamide Chemical compound CN[C@H](CO)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F FSQFMRBMEQDTGM-SNVBAGLBSA-N 0.000 description 1
- FSQFMRBMEQDTGM-JTQLQIEISA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[(2s)-3-hydroxy-2-(methylamino)propoxy]benzamide Chemical compound CN[C@@H](CO)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F FSQFMRBMEQDTGM-JTQLQIEISA-N 0.000 description 1
- ZUNRTXWQUYMXIM-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[2-hydroxy-3-(methylamino)propoxy]benzamide Chemical compound CNCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F ZUNRTXWQUYMXIM-UHFFFAOYSA-N 0.000 description 1
- HHPLAAVNKNPHLC-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[[1-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound C=1C=C(F)C(F)=C(NC=2C(=CC(I)=CC=2)F)C=1C(=O)NOCC1(CO)CC1 HHPLAAVNKNPHLC-UHFFFAOYSA-N 0.000 description 1
- VQTPNADDEIMRRU-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[[2-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound OCC1CC1CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F VQTPNADDEIMRRU-UHFFFAOYSA-N 0.000 description 1
- FELSTRWYNIIENJ-UHFFFAOYSA-N 3,4-difluoro-2-(2-fluoroanilino)-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=CC=C1F FELSTRWYNIIENJ-UHFFFAOYSA-N 0.000 description 1
- HKQZCPXQBHIKRU-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(2-methoxyethoxy)benzamide Chemical compound COCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C HKQZCPXQBHIKRU-UHFFFAOYSA-N 0.000 description 1
- HDLXUSUTCIBXQZ-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(2-methylprop-2-enoxy)benzamide Chemical compound CC(=C)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C HDLXUSUTCIBXQZ-UHFFFAOYSA-N 0.000 description 1
- DLEORGDKUULNIF-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(3,3,3-trifluoro-2-hydroxypropoxy)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC(O)C(F)(F)F DLEORGDKUULNIF-UHFFFAOYSA-N 0.000 description 1
- ILKRGOONQZFQPI-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(3-methyl-5-phenylpent-2-en-4-ynoxy)benzamide Chemical compound C=1C=CC=CC=1C#CC(C)=CCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C ILKRGOONQZFQPI-UHFFFAOYSA-N 0.000 description 1
- RLUBNNSZZPDBIV-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(3-phenylprop-2-ynoxy)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC#CC1=CC=CC=C1 RLUBNNSZZPDBIV-UHFFFAOYSA-N 0.000 description 1
- HAONTWSXIVMMHV-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(thiophen-2-ylmethoxy)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC1=CC=CS1 HAONTWSXIVMMHV-UHFFFAOYSA-N 0.000 description 1
- XBBYDBSSUSYRRN-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-[2-(2,2,2-trifluoroethylamino)ethoxy]benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCNCC(F)(F)F XBBYDBSSUSYRRN-UHFFFAOYSA-N 0.000 description 1
- QBPQFDBZSSLDGD-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-[2-(2-methoxyethoxy)ethoxy]benzamide Chemical compound COCCOCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C QBPQFDBZSSLDGD-UHFFFAOYSA-N 0.000 description 1
- OKAOLVGZYFXUAV-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-[2-(methylamino)ethoxy]benzamide Chemical compound CNCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C OKAOLVGZYFXUAV-UHFFFAOYSA-N 0.000 description 1
- FUDMVYZZNQDLOV-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)-n-propoxybenzamide Chemical compound CCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C FUDMVYZZNQDLOV-UHFFFAOYSA-N 0.000 description 1
- XRNCNLRJMNWXRG-UHFFFAOYSA-N 3,4-difluoro-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(O)=O XRNCNLRJMNWXRG-UHFFFAOYSA-N 0.000 description 1
- DADGHVDWQXEJGZ-UHFFFAOYSA-N 3,4-difluoro-n-(1-hydroxy-2-methylpropan-2-yl)oxy-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOC(C)(C)CO DADGHVDWQXEJGZ-UHFFFAOYSA-N 0.000 description 1
- VMYUHTXVYPAJJT-UHFFFAOYSA-N 3,4-difluoro-n-(1-hydroxypropan-2-yloxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound OCC(C)ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C VMYUHTXVYPAJJT-UHFFFAOYSA-N 0.000 description 1
- KTBMEVXATBDVQF-UHFFFAOYSA-N 3,4-difluoro-n-(2-hydroxy-2-methylpropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC(C)(C)O KTBMEVXATBDVQF-UHFFFAOYSA-N 0.000 description 1
- KGDZSEGBJANPRB-UHFFFAOYSA-N 3,4-difluoro-n-(2-hydroxy-3-methoxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound COCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C KGDZSEGBJANPRB-UHFFFAOYSA-N 0.000 description 1
- PNAAHTJLZYNALC-UHFFFAOYSA-N 3,4-difluoro-n-(2-hydroxyethoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCO PNAAHTJLZYNALC-UHFFFAOYSA-N 0.000 description 1
- ONIJBBRUJFSGCR-UHFFFAOYSA-N 3,4-difluoro-n-(2-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C ONIJBBRUJFSGCR-UHFFFAOYSA-N 0.000 description 1
- OEYRWOJRMOBKSM-UHFFFAOYSA-N 3,4-difluoro-n-[3-(2-fluorophenyl)prop-2-ynoxy]-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC#CC1=CC=CC=C1F OEYRWOJRMOBKSM-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000006192 3-phenylprop-2-enyl group Chemical group [H]\C(=C(\[H])C([H])([H])*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- LEJARSYDJCFZGG-UHFFFAOYSA-N 4,5-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxy-3-morpholin-4-ylpropoxy)benzamide Chemical compound C1COCCN1CC(O)CONC(=O)C1=CC(F)=C(F)C=C1NC1=CC=C(I)C=C1F LEJARSYDJCFZGG-UHFFFAOYSA-N 0.000 description 1
- XJPSSHUZQIVRJO-UHFFFAOYSA-N 4,5-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(F)=C(F)C=C1NC1=CC=C(I)C=C1F XJPSSHUZQIVRJO-UHFFFAOYSA-N 0.000 description 1
- NZLBVPZBNGBXPI-UHFFFAOYSA-N 4,5-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(F)=C(F)C=C1NC1=CC=C(I)C=C1F NZLBVPZBNGBXPI-UHFFFAOYSA-N 0.000 description 1
- CXSZSQUWJRPCSK-UHFFFAOYSA-N 4,5-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC(F)=C(F)C=C1NC1=CC=C(I)C=C1F CXSZSQUWJRPCSK-UHFFFAOYSA-N 0.000 description 1
- XUNXEVMAIKEENT-UHFFFAOYSA-N 4,5-difluoro-2-(2-fluoro-4-iodoanilino)-n-[[1-(hydroxymethyl)cyclopropyl]methoxy]benzamide Chemical compound C=1C(F)=C(F)C=C(NC=2C(=CC(I)=CC=2)F)C=1C(=O)NOCC1(CO)CC1 XUNXEVMAIKEENT-UHFFFAOYSA-N 0.000 description 1
- UYABRWWTZQZEDR-UHFFFAOYSA-N 4,5-difluoro-n-(2-hydroxyethoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=C(F)C=C1C(=O)NOCCO UYABRWWTZQZEDR-UHFFFAOYSA-N 0.000 description 1
- FYFHVQLFQOKLEM-UHFFFAOYSA-N 4-chloro-4-iodo-6-methyl-6-(2h-tetrazol-5-yl)cyclohex-2-en-1-amine Chemical compound N1=NNN=C1C1(C)CC(Cl)(I)C=CC1N FYFHVQLFQOKLEM-UHFFFAOYSA-N 0.000 description 1
- FQELXZARENTIKS-UHFFFAOYSA-N 4-fluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1F FQELXZARENTIKS-UHFFFAOYSA-N 0.000 description 1
- GHJJMBQQZZBWJC-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1C GHJJMBQQZZBWJC-UHFFFAOYSA-N 0.000 description 1
- XYPDOWBXGOOEOA-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)-n-(2-phenoxyethoxy)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NOCCOC1=CC=CC=C1 XYPDOWBXGOOEOA-UHFFFAOYSA-N 0.000 description 1
- PBAMOEUDSFIDGM-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)-n-(thiophen-2-ylmethoxy)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NOCC1=CC=CS1 PBAMOEUDSFIDGM-UHFFFAOYSA-N 0.000 description 1
- HHSBHFSKYJRNAR-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1C HHSBHFSKYJRNAR-UHFFFAOYSA-N 0.000 description 1
- WOHHWWLIRJXRJT-UHFFFAOYSA-N 4-fluoro-2-(4-iodo-2-methylanilino)-n-propylbenzamide Chemical compound CCCNC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1C WOHHWWLIRJXRJT-UHFFFAOYSA-N 0.000 description 1
- KQBLIJZTHLEFFL-UHFFFAOYSA-N 4-fluoro-n-(2-hydroxyethoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NOCCO KQBLIJZTHLEFFL-UHFFFAOYSA-N 0.000 description 1
- PJMHNOKJJUERIL-UHFFFAOYSA-N 4-fluoro-n-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=CC=C1C(=O)NCCCN1CCN(CCO)CC1 PJMHNOKJJUERIL-UHFFFAOYSA-N 0.000 description 1
- ZESWUEBPRPGMTP-UHFFFAOYSA-N 4-nitrobenzamide Chemical compound NC(=O)C1=CC=C([N+]([O-])=O)C=C1 ZESWUEBPRPGMTP-UHFFFAOYSA-N 0.000 description 1
- JAJYJOVHOFOWJR-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(1-hydroxy-2-methylpropan-2-yl)oxybenzamide Chemical compound OCC(C)(C)ONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl JAJYJOVHOFOWJR-UHFFFAOYSA-N 0.000 description 1
- DZYJPJTZIZMARC-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl DZYJPJTZIZMARC-UHFFFAOYSA-N 0.000 description 1
- YEGYPQZEUQHTBQ-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-3-methoxypropoxy)benzamide Chemical compound COCC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl YEGYPQZEUQHTBQ-UHFFFAOYSA-N 0.000 description 1
- VRJXSASHUSQFGC-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-3-morpholin-4-ylpropoxy)benzamide Chemical compound C1COCCN1CC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl VRJXSASHUSQFGC-UHFFFAOYSA-N 0.000 description 1
- DCLSOIXXCBNLBR-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-3-phenoxypropoxy)benzamide Chemical compound C=1C=CC=CC=1OCC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl DCLSOIXXCBNLBR-UHFFFAOYSA-N 0.000 description 1
- HRABIHHENHSTBS-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl HRABIHHENHSTBS-UHFFFAOYSA-N 0.000 description 1
- FLCWOHGNXRCDIW-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl FLCWOHGNXRCDIW-UHFFFAOYSA-N 0.000 description 1
- QYQQDHPSPQPRHS-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-methoxyethoxy)benzamide Chemical compound COCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl QYQQDHPSPQPRHS-UHFFFAOYSA-N 0.000 description 1
- HSOHARZKALUJED-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(3,3,3-trifluoro-2-hydroxypropoxy)benzamide Chemical compound FC(F)(F)C(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl HSOHARZKALUJED-UHFFFAOYSA-N 0.000 description 1
- ABZYJPZAHRKQQX-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-[2-(2-methoxyethoxy)ethoxy]benzamide Chemical compound COCCOCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl ABZYJPZAHRKQQX-UHFFFAOYSA-N 0.000 description 1
- HBZJICXEFBXBFX-UHFFFAOYSA-N 5-bromo-2-(2-chloro-4-iodoanilino)-n-(2,3-dihydroxypropoxy)-3,4-difluorobenzamide Chemical compound OCC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl HBZJICXEFBXBFX-UHFFFAOYSA-N 0.000 description 1
- RMMHDUKPOBKFRU-UHFFFAOYSA-N 5-bromo-2-(2-ethyl-4-iodoanilino)-n-(2-pyrrolidin-1-ylethyl)benzamide Chemical compound CCC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NCCN1CCCC1 RMMHDUKPOBKFRU-UHFFFAOYSA-N 0.000 description 1
- YGSACSKOTDWEIY-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC(Br)=CC=C1NC1=CC=C(I)C=C1C YGSACSKOTDWEIY-UHFFFAOYSA-N 0.000 description 1
- KACROHVGLWUBCA-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)-n-(2-morpholin-4-ylethyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NCCN1CCOCC1 KACROHVGLWUBCA-UHFFFAOYSA-N 0.000 description 1
- IAVNIGIRNWGCLU-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)-n-(2-piperidin-1-ylethyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NCCN1CCCCC1 IAVNIGIRNWGCLU-UHFFFAOYSA-N 0.000 description 1
- MXCDWFRGCXEWHI-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)-n-[(3-methylphenyl)methyl]benzamide Chemical compound CC1=CC=CC(CNC(=O)C=2C(=CC=C(Br)C=2)NC=2C(=CC(I)=CC=2)C)=C1 MXCDWFRGCXEWHI-UHFFFAOYSA-N 0.000 description 1
- GTXGFBQHXPMFRF-UHFFFAOYSA-N 5-bromo-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(N)=O GTXGFBQHXPMFRF-UHFFFAOYSA-N 0.000 description 1
- RNNWGGLSXCTSOW-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(1-hydroxypropan-2-yloxy)benzamide Chemical compound OCC(C)ONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1F RNNWGGLSXCTSOW-UHFFFAOYSA-N 0.000 description 1
- OLXAFJHNJCUYKV-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1F OLXAFJHNJCUYKV-UHFFFAOYSA-N 0.000 description 1
- CSXIOTHCMKSONM-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1F CSXIOTHCMKSONM-UHFFFAOYSA-N 0.000 description 1
- JGUJNCYXMKPUNI-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1F JGUJNCYXMKPUNI-UHFFFAOYSA-N 0.000 description 1
- LUAWFZQWIXYGPQ-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-hydroxybenzamide Chemical compound ONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1F LUAWFZQWIXYGPQ-UHFFFAOYSA-N 0.000 description 1
- IGYYSPKYFOAVCF-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(2-methoxyethoxy)benzamide Chemical compound COCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C IGYYSPKYFOAVCF-UHFFFAOYSA-N 0.000 description 1
- CYHKFEHMDJDUCY-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-(pyridin-3-ylmethoxy)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCC1=CC=CN=C1 CYHKFEHMDJDUCY-UHFFFAOYSA-N 0.000 description 1
- VFYMNDDKUCPFNV-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-[2-(2-methoxyethoxy)ethoxy]benzamide Chemical compound COCCOCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C VFYMNDDKUCPFNV-UHFFFAOYSA-N 0.000 description 1
- JDYMILCDQZFLCK-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-prop-2-ynoxybenzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCC#C JDYMILCDQZFLCK-UHFFFAOYSA-N 0.000 description 1
- NCTFSDXSASAYPI-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)-n-propan-2-yloxybenzamide Chemical compound CC(C)ONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C NCTFSDXSASAYPI-UHFFFAOYSA-N 0.000 description 1
- IHCADDZQYYEXFH-UHFFFAOYSA-N 5-bromo-3,4-difluoro-2-(4-iodo-2-methylanilino)benzoic acid Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(O)=O IHCADDZQYYEXFH-UHFFFAOYSA-N 0.000 description 1
- YGNFDTBECCMKNX-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(2-hydroxy-2-methylpropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCC(C)(C)O YGNFDTBECCMKNX-UHFFFAOYSA-N 0.000 description 1
- DSNSWZOBIUQUBS-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(2-hydroxyethyl)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NCCO DSNSWZOBIUQUBS-UHFFFAOYSA-N 0.000 description 1
- GGOAXZTZGSUYHP-UHFFFAOYSA-N 5-bromo-3,4-difluoro-n-(2-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC(O)CONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C GGOAXZTZGSUYHP-UHFFFAOYSA-N 0.000 description 1
- CQPSMBQJOXWKER-UHFFFAOYSA-N 5-bromo-4-fluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(Br)=C(F)C=C1NC1=CC=C(I)C=C1F CQPSMBQJOXWKER-UHFFFAOYSA-N 0.000 description 1
- YMCDQJQIFPNVQN-UHFFFAOYSA-N 5-bromo-4-fluoro-n-(2-hydroxyethoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC(F)=C(Br)C=C1C(=O)NOCCO YMCDQJQIFPNVQN-UHFFFAOYSA-N 0.000 description 1
- KSZAZDSTXSHLEM-UHFFFAOYSA-N 5-bromo-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCC(O)CO KSZAZDSTXSHLEM-UHFFFAOYSA-N 0.000 description 1
- JPXJXKWFQMNGHC-UHFFFAOYSA-N 5-bromo-n-(2-ethenoxyethoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound FC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCCOC=C JPXJXKWFQMNGHC-UHFFFAOYSA-N 0.000 description 1
- ISUGUEODQSICNU-UHFFFAOYSA-N 5-bromo-n-(3,4-dihydroxybutoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCCC(O)CO ISUGUEODQSICNU-UHFFFAOYSA-N 0.000 description 1
- PADIEEAWBNJBQS-UHFFFAOYSA-N 5-bromo-n-(3-hydroxypropyl)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1C(=O)NCCCO PADIEEAWBNJBQS-UHFFFAOYSA-N 0.000 description 1
- PHJXBTSQFDDWJS-UHFFFAOYSA-N 5-bromo-n-(cyclopropylmethoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound FC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCC1CC1 PHJXBTSQFDDWJS-UHFFFAOYSA-N 0.000 description 1
- JUVFXZWQSKISCB-UHFFFAOYSA-N 5-bromo-n-(cyclopropylmethoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Br)C=C1C(=O)NOCC1CC1 JUVFXZWQSKISCB-UHFFFAOYSA-N 0.000 description 1
- IVARVMGCQQJYCS-UHFFFAOYSA-N 5-bromo-n-[2-[di(propan-2-yl)amino]ethyl]-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC(C)N(C(C)C)CCNC(=O)C1=CC(Br)=CC=C1NC1=CC=C(I)C=C1C IVARVMGCQQJYCS-UHFFFAOYSA-N 0.000 description 1
- YUKGGEUVPFOCFI-UHFFFAOYSA-N 5-bromo-n-[3-(dimethylamino)propyl]-2-(4-iodo-2-methylanilino)benzamide Chemical compound CN(C)CCCNC(=O)C1=CC(Br)=CC=C1NC1=CC=C(I)C=C1C YUKGGEUVPFOCFI-UHFFFAOYSA-N 0.000 description 1
- JETNCDYHKNDALF-UHFFFAOYSA-N 5-bromo-n-[3-(dimethylamino)propyl]-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CN(C)CCCNC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C JETNCDYHKNDALF-UHFFFAOYSA-N 0.000 description 1
- HXACAYXLBFGWMG-UHFFFAOYSA-N 5-bromo-n-ethoxy-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C HXACAYXLBFGWMG-UHFFFAOYSA-N 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- LTJORRDKSUXIIG-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F LTJORRDKSUXIIG-UHFFFAOYSA-N 0.000 description 1
- HQLMYCXRLIQWLB-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxy-3-morpholin-4-ylpropoxy)benzamide Chemical compound C1COCCN1CC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F HQLMYCXRLIQWLB-UHFFFAOYSA-N 0.000 description 1
- KCPUBYHTMMZAFC-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxy-3-phenoxypropoxy)benzamide Chemical compound C=1C=CC=CC=1OCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F KCPUBYHTMMZAFC-UHFFFAOYSA-N 0.000 description 1
- XWMUXONQNUBXQC-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F XWMUXONQNUBXQC-UHFFFAOYSA-N 0.000 description 1
- WQJYAGCYAZJXLZ-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F WQJYAGCYAZJXLZ-UHFFFAOYSA-N 0.000 description 1
- UTHDWCFBPZVMMS-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F UTHDWCFBPZVMMS-UHFFFAOYSA-N 0.000 description 1
- GAFXEMDPFPMLRK-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(3,3,3-trifluoro-2-hydroxypropoxy)benzamide Chemical compound FC(F)(F)C(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F GAFXEMDPFPMLRK-UHFFFAOYSA-N 0.000 description 1
- KLJFZUURDVVGDV-UHFFFAOYSA-N 5-chloro-2-(2,4-difluoroanilino)-3,4-difluoro-n-(3-hydroxy-2,2-dimethylpropoxy)benzamide Chemical compound OCC(C)(C)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(F)C=C1F KLJFZUURDVVGDV-UHFFFAOYSA-N 0.000 description 1
- NUUOGSDHAYBJLD-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(1-hydroxypropan-2-yloxy)benzamide Chemical compound OCC(C)ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl NUUOGSDHAYBJLD-UHFFFAOYSA-N 0.000 description 1
- RUWLBBORGVOXHY-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl RUWLBBORGVOXHY-UHFFFAOYSA-N 0.000 description 1
- CAOXBPNEXJXFAE-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(2-hydroxy-3-morpholin-4-ylpropoxy)benzamide Chemical compound C1COCCN1CC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl CAOXBPNEXJXFAE-UHFFFAOYSA-N 0.000 description 1
- AEDCKUDYWIVKSE-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-(3-hydroxy-2,2-dimethylpropoxy)benzamide Chemical compound OCC(C)(C)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl AEDCKUDYWIVKSE-UHFFFAOYSA-N 0.000 description 1
- JJRPFRJFSCURRA-SECBINFHSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-[(2r)-3-hydroxy-2-(methylamino)propoxy]benzamide Chemical compound CN[C@H](CO)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl JJRPFRJFSCURRA-SECBINFHSA-N 0.000 description 1
- JJRPFRJFSCURRA-VIFPVBQESA-N 5-chloro-2-(2-chloro-4-iodoanilino)-3,4-difluoro-n-[(2s)-3-hydroxy-2-(methylamino)propoxy]benzamide Chemical compound CN[C@@H](CO)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl JJRPFRJFSCURRA-VIFPVBQESA-N 0.000 description 1
- SYNKSDFBUKBUGC-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-n-(3,4-dihydroxybutoxy)-3,4-difluorobenzamide Chemical compound OCC(O)CCONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl SYNKSDFBUKBUGC-UHFFFAOYSA-N 0.000 description 1
- YGRHTDDIYZYUDW-UHFFFAOYSA-N 5-chloro-2-(2-chloro-4-iodoanilino)-n-(cyclopropylmethoxy)-3,4-difluorobenzamide Chemical compound C=1C=C(I)C=C(Cl)C=1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCC1CC1 YGRHTDDIYZYUDW-UHFFFAOYSA-N 0.000 description 1
- LVSSVNULIKSVNX-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC(Cl)=CC=C1NC1=CC=C(I)C=C1C LVSSVNULIKSVNX-UHFFFAOYSA-N 0.000 description 1
- UQFNVBACOUIFNY-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)-n-(2-piperidin-1-ylethyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NCCN1CCCCC1 UQFNVBACOUIFNY-UHFFFAOYSA-N 0.000 description 1
- DESOLFCZYNVVHJ-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)-n-(2-pyrrolidin-1-ylethyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NCCN1CCCC1 DESOLFCZYNVVHJ-UHFFFAOYSA-N 0.000 description 1
- ANJGKWAYKBLXEK-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)-n-(3-piperidin-1-ylpropyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NCCCN1CCCCC1 ANJGKWAYKBLXEK-UHFFFAOYSA-N 0.000 description 1
- HFKKIAJNJRTIFR-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)-n-(oxan-2-yloxy)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NOC1OCCCC1 HFKKIAJNJRTIFR-UHFFFAOYSA-N 0.000 description 1
- RTCMPVBAZMDRHK-UHFFFAOYSA-N 5-chloro-2-(4-iodo-2-methylanilino)-n-[(3-methylphenyl)methyl]benzamide Chemical compound CC1=CC=CC(CNC(=O)C=2C(=CC=C(Cl)C=2)NC=2C(=CC(I)=CC=2)C)=C1 RTCMPVBAZMDRHK-UHFFFAOYSA-N 0.000 description 1
- XYPLXJVKPNETLX-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(1-hydroxy-2-methylpropan-2-yl)oxybenzamide Chemical compound OCC(C)(C)ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F XYPLXJVKPNETLX-UHFFFAOYSA-N 0.000 description 1
- PFDNYXXLINPMBE-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(1-hydroxypropan-2-yloxy)benzamide Chemical compound OCC(C)ONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F PFDNYXXLINPMBE-UHFFFAOYSA-N 0.000 description 1
- HETQJETVXZFQTG-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxy-2-methylpropoxy)benzamide Chemical compound CC(C)(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F HETQJETVXZFQTG-UHFFFAOYSA-N 0.000 description 1
- JQNWJUDGIGTBFP-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxy-3-morpholin-4-ylpropoxy)benzamide Chemical compound C1COCCN1CC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F JQNWJUDGIGTBFP-UHFFFAOYSA-N 0.000 description 1
- AWKYIAXCHTZLNJ-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxy-3-phenoxypropoxy)benzamide Chemical compound C=1C=CC=CC=1OCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F AWKYIAXCHTZLNJ-UHFFFAOYSA-N 0.000 description 1
- YDBVNNDWJVRMMC-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxybutoxy)benzamide Chemical compound CCC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F YDBVNNDWJVRMMC-UHFFFAOYSA-N 0.000 description 1
- YKRZOJLUPHPUGG-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxyethoxy)benzamide Chemical compound OCCONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F YKRZOJLUPHPUGG-UHFFFAOYSA-N 0.000 description 1
- HTKZEKURWOHLMF-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-hydroxypropoxy)benzamide Chemical compound CC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F HTKZEKURWOHLMF-UHFFFAOYSA-N 0.000 description 1
- VAWRKCMPZUVOIR-UHFFFAOYSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-(2-methoxyethoxy)benzamide Chemical compound COCCONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F VAWRKCMPZUVOIR-UHFFFAOYSA-N 0.000 description 1
- RDLJHNVMINSXOA-SECBINFHSA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[(2r)-3-hydroxy-2-(methylamino)propoxy]benzamide Chemical compound CN[C@H](CO)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F RDLJHNVMINSXOA-SECBINFHSA-N 0.000 description 1
- RDLJHNVMINSXOA-VIFPVBQESA-N 5-chloro-3,4-difluoro-2-(2-fluoro-4-iodoanilino)-n-[(2s)-3-hydroxy-2-(methylamino)propoxy]benzamide Chemical compound CN[C@@H](CO)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1F RDLJHNVMINSXOA-VIFPVBQESA-N 0.000 description 1
- HHJBPWBCMBOOKC-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(2-hydroxy-2-methylpropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCC(C)(C)O HHJBPWBCMBOOKC-UHFFFAOYSA-N 0.000 description 1
- LEQSQAVMKRTQKP-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(2-hydroxyethoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCCO LEQSQAVMKRTQKP-UHFFFAOYSA-N 0.000 description 1
- PLSVLFSKBZNCLU-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(2-hydroxyethoxy)-2-(4-iodoanilino)benzamide Chemical compound OCCONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1 PLSVLFSKBZNCLU-UHFFFAOYSA-N 0.000 description 1
- CSHDSARJAOHKFT-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(2-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC(O)CONC(=O)C1=CC(Cl)=C(F)C(F)=C1NC1=CC=C(I)C=C1C CSHDSARJAOHKFT-UHFFFAOYSA-N 0.000 description 1
- FILGGVYCRKUYLH-UHFFFAOYSA-N 5-chloro-3,4-difluoro-n-(3-hydroxypropoxy)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCCCO FILGGVYCRKUYLH-UHFFFAOYSA-N 0.000 description 1
- FZJKEESBPVPDBV-UHFFFAOYSA-N 5-chloro-n,n-diethyl-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCN(CC)C(=O)C1=CC(Cl)=CC=C1NC1=CC=C(I)C=C1C FZJKEESBPVPDBV-UHFFFAOYSA-N 0.000 description 1
- NNPZJZZZVASQEN-UHFFFAOYSA-N 5-chloro-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCC(O)CO NNPZJZZZVASQEN-UHFFFAOYSA-N 0.000 description 1
- IQYTUFVYAKHKQB-UHFFFAOYSA-N 5-chloro-n-(2-ethenoxyethoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound FC1=CC(I)=CC=C1NC1=C(F)C(F)=C(Cl)C=C1C(=O)NOCCOC=C IQYTUFVYAKHKQB-UHFFFAOYSA-N 0.000 description 1
- IHNKPBIVPDAOMS-UHFFFAOYSA-N 5-chloro-n-(3-hydroxypropyl)-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1C(=O)NCCCO IHNKPBIVPDAOMS-UHFFFAOYSA-N 0.000 description 1
- WPTQCTMJDFCZSI-UHFFFAOYSA-N 5-chloro-n-[2-(diethylamino)ethyl]-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=CC=C1NC1=CC=C(I)C=C1C WPTQCTMJDFCZSI-UHFFFAOYSA-N 0.000 description 1
- TUWOHSIPLLUTFB-UHFFFAOYSA-N 5-chloro-n-[2-[di(propan-2-yl)amino]ethyl]-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC(C)N(C(C)C)CCNC(=O)C1=CC(Cl)=CC=C1NC1=CC=C(I)C=C1C TUWOHSIPLLUTFB-UHFFFAOYSA-N 0.000 description 1
- XNAJEOYTSSBCFU-UHFFFAOYSA-N 5-chloro-n-[3-(diethylamino)-2-hydroxypropyl]-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCN(CC)CC(O)CNC(=O)C1=CC(Cl)=CC=C1NC1=CC=C(I)C=C1C XNAJEOYTSSBCFU-UHFFFAOYSA-N 0.000 description 1
- OQWXTWHGTZIWBE-UHFFFAOYSA-N 5-chloro-n-[3-(dimethylamino)propyl]-2-(4-iodo-2-methylanilino)benzamide Chemical compound CN(C)CCCNC(=O)C1=CC(Cl)=CC=C1NC1=CC=C(I)C=C1C OQWXTWHGTZIWBE-UHFFFAOYSA-N 0.000 description 1
- RMDPNUIMTHQHBO-UHFFFAOYSA-N 5-fluoro-2-(4-iodo-2-methylanilino)-n-(2-morpholin-4-ylethyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(F)C=C1C(=O)NCCN1CCOCC1 RMDPNUIMTHQHBO-UHFFFAOYSA-N 0.000 description 1
- ADRDDDZHIAHVOS-UHFFFAOYSA-N 5-fluoro-2-(4-iodo-2-methylanilino)-n-(pyridin-4-ylmethyl)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(F)C=C1C(=O)NCC1=CC=NC=C1 ADRDDDZHIAHVOS-UHFFFAOYSA-N 0.000 description 1
- LOUSDJOLFFYIHT-UHFFFAOYSA-N 5-iodo-2-(4-iodo-2-methylanilino)-n-[(4-sulfamoylphenyl)methyl]benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(I)C=C1C(=O)NCC1=CC=C(S(N)(=O)=O)C=C1 LOUSDJOLFFYIHT-UHFFFAOYSA-N 0.000 description 1
- ISSKCCWEUYSNQW-UHFFFAOYSA-N 5-iodo-2-(4-iodo-2-methylanilino)-n-methyl-n-phenylbenzamide Chemical compound C=1C=CC=CC=1N(C)C(=O)C1=CC(I)=CC=C1NC1=CC=C(I)C=C1C ISSKCCWEUYSNQW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 description 1
- BHHBGJUZEPKYTF-UHFFFAOYSA-N CCCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C.CC=CCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C Chemical compound CCCCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C.CC=CCONC(=O)C1=CC(Br)=C(F)C(F)=C1NC1=CC=C(I)C=C1C BHHBGJUZEPKYTF-UHFFFAOYSA-N 0.000 description 1
- 108050006947 CXC Chemokine Proteins 0.000 description 1
- 102000019388 CXC chemokine Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 102000009410 Chemokine receptor Human genes 0.000 description 1
- 108050000299 Chemokine receptor Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 1
- 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- XYZZKVRWGOWVGO-UHFFFAOYSA-N Glycerol-phosphate Chemical compound OP(O)(O)=O.OCC(O)CO XYZZKVRWGOWVGO-UHFFFAOYSA-N 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 102100021892 Inhibitor of nuclear factor kappa-B kinase subunit alpha Human genes 0.000 description 1
- 101710110357 Inhibitor of nuclear factor kappa-B kinase subunit alpha Proteins 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108060006687 MAP kinase kinase kinase Proteins 0.000 description 1
- 239000012820 MEK1 Inhibitor Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010029379 Neutrophilia Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- SUDAHWBOROXANE-VIFPVBQESA-N PD 0325901-Cl Chemical compound OC[C@H](O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F SUDAHWBOROXANE-VIFPVBQESA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 206010035551 Pleocytosis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N Stearinsaeure-hexadecylester Natural products CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 238000012298 Transwell chamber assay Methods 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- PNWJMZMIJSAVRR-UHFFFAOYSA-N [2-(4-iodo-2-methylanilino)-5-nitrophenyl]methanol Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1CO PNWJMZMIJSAVRR-UHFFFAOYSA-N 0.000 description 1
- ZMASSHMGXOJPAC-UHFFFAOYSA-N [3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]-(4-hydroxy-1,2-oxazolidin-2-yl)methanone Chemical compound C1C(O)CON1C(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F ZMASSHMGXOJPAC-UHFFFAOYSA-N 0.000 description 1
- QAFJIVFPYARMAT-UHFFFAOYSA-N [5-bromo-2-(4-iodo-2-methylanilino)phenyl]methanol Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Br)C=C1CO QAFJIVFPYARMAT-UHFFFAOYSA-N 0.000 description 1
- KARCBUCWSFRWNA-UHFFFAOYSA-N [5-chloro-2-(4-iodo-2-methylanilino)phenyl]methanol Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(Cl)C=C1CO KARCBUCWSFRWNA-UHFFFAOYSA-N 0.000 description 1
- QPQGTZMAQRXCJW-UHFFFAOYSA-N [chloro(phenyl)phosphoryl]benzene Chemical compound C=1C=CC=CC=1P(=O)(Cl)C1=CC=CC=C1 QPQGTZMAQRXCJW-UHFFFAOYSA-N 0.000 description 1
- 239000003655 absorption accelerator Substances 0.000 description 1
- 150000001241 acetals Chemical group 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000009218 additive inhibitory effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000005741 alkyl alkenyl group Chemical group 0.000 description 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000006229 amino acid addition Effects 0.000 description 1
- 125000005021 aminoalkenyl group Chemical group 0.000 description 1
- 125000005014 aminoalkynyl group Chemical group 0.000 description 1
- 125000005001 aminoaryl group Chemical group 0.000 description 1
- 125000005124 aminocycloalkyl group Chemical group 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 150000003938 benzyl alcohols Chemical class 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004966 cyanoalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical group C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- UCQFCFPECQILOL-UHFFFAOYSA-N diethyl hydrogen phosphate Chemical compound CCOP(O)(=O)OCC UCQFCFPECQILOL-UHFFFAOYSA-N 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002009 diols Chemical group 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 125000006379 fluoropyridyl group Chemical group 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000003106 haloaryl group Chemical group 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 102000052624 human CXCL8 Human genes 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012642 immune effector Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- SKMCJUSFAIWLJG-UHFFFAOYSA-N n,n-diethyl-2-(4-iodo-2-methylanilino)-5-nitrobenzamide Chemical compound CCN(CC)C(=O)C1=CC([N+]([O-])=O)=CC=C1NC1=CC=C(I)C=C1C SKMCJUSFAIWLJG-UHFFFAOYSA-N 0.000 description 1
- PINUTQQQUYREAM-UHFFFAOYSA-N n,n-diethyl-4-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCN(CC)C(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1C PINUTQQQUYREAM-UHFFFAOYSA-N 0.000 description 1
- HHAQCCFWGZJFNF-UHFFFAOYSA-N n-(2,3-dihydroxy-3-methylbutoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound CC(C)(O)C(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F HHAQCCFWGZJFNF-UHFFFAOYSA-N 0.000 description 1
- YAKWAGKBYPGQIY-UHFFFAOYSA-N n-(2,3-dihydroxypropoxy)-3,4,5-trifluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(=O)NOCC(O)CO YAKWAGKBYPGQIY-UHFFFAOYSA-N 0.000 description 1
- RHILBKCNHBLDBK-UHFFFAOYSA-N n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoroanilino)benzamide Chemical compound OCC(O)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=CC=C1F RHILBKCNHBLDBK-UHFFFAOYSA-N 0.000 description 1
- DHPQWOUFUGVWQX-UHFFFAOYSA-N n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCC(O)CO DHPQWOUFUGVWQX-UHFFFAOYSA-N 0.000 description 1
- MUYJQNPLHDCKQV-UHFFFAOYSA-N n-(2-anilinoethoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCNC1=CC=CC=C1 MUYJQNPLHDCKQV-UHFFFAOYSA-N 0.000 description 1
- HAQSWDSKPIEDJA-UHFFFAOYSA-N n-(2-anilinoethoxy)-5-bromo-2-(2-chloro-4-iodoanilino)-3,4-difluorobenzamide Chemical compound C=1C=CC=CC=1NCCONC(=O)C=1C=C(Br)C(F)=C(F)C=1NC1=CC=C(I)C=C1Cl HAQSWDSKPIEDJA-UHFFFAOYSA-N 0.000 description 1
- KLGYZKCFSRHPJL-UHFFFAOYSA-N n-(2-ethenoxyethoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound FC1=CC=C(C(=O)NOCCOC=C)C(NC=2C(=CC(I)=CC=2)F)=C1F KLGYZKCFSRHPJL-UHFFFAOYSA-N 0.000 description 1
- FAMMFQUDGRXIMB-UHFFFAOYSA-N n-(3,4-dihydroxybutoxy)-3,4,5-trifluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=C(F)C=C1C(=O)NOCCC(O)CO FAMMFQUDGRXIMB-UHFFFAOYSA-N 0.000 description 1
- LWOTWORCKOTPCH-UHFFFAOYSA-N n-(3,4-dihydroxybutoxy)-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOCCC(O)CO LWOTWORCKOTPCH-UHFFFAOYSA-N 0.000 description 1
- DMGLLVWXKXWTIL-UHFFFAOYSA-N n-(3-hydroxypropyl)-2-(4-iodo-2-methylanilino)-5-nitrobenzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C([N+]([O-])=O)C=C1C(=O)NCCCO DMGLLVWXKXWTIL-UHFFFAOYSA-N 0.000 description 1
- DQHARHQBVRLSQS-UHFFFAOYSA-N n-(cyclopropylmethoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound C=1C=C(I)C=C(F)C=1NC1=C(F)C(F)=CC=C1C(=O)NOCC1CC1 DQHARHQBVRLSQS-UHFFFAOYSA-N 0.000 description 1
- USZQGSWPCMGRPH-UHFFFAOYSA-N n-[(2,2-dimethyl-1,3-dioxan-5-yl)oxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide Chemical compound C1OC(C)(C)OCC1ONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F USZQGSWPCMGRPH-UHFFFAOYSA-N 0.000 description 1
- HDYUNAODPNRHCT-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-5-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCN(CC)CCNC(=O)C1=CC(F)=CC=C1NC1=CC=C(I)C=C1C HDYUNAODPNRHCT-UHFFFAOYSA-N 0.000 description 1
- XQLIVOYIWQHNST-UHFFFAOYSA-N n-[3-(diethylamino)-2-hydroxypropyl]-5-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCN(CC)CC(O)CNC(=O)C1=CC(F)=CC=C1NC1=CC=C(I)C=C1C XQLIVOYIWQHNST-UHFFFAOYSA-N 0.000 description 1
- RYONWGDKFMCGQK-UHFFFAOYSA-N n-[3-(diethylamino)propyl]-2-(4-iodo-2-methylanilino)-5-nitrobenzamide Chemical compound CCN(CC)CCCNC(=O)C1=CC([N+]([O-])=O)=CC=C1NC1=CC=C(I)C=C1C RYONWGDKFMCGQK-UHFFFAOYSA-N 0.000 description 1
- IKFPRHQBWHOCKH-UHFFFAOYSA-N n-[3-(diethylamino)propyl]-5-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCN(CC)CCCNC(=O)C1=CC(F)=CC=C1NC1=CC=C(I)C=C1C IKFPRHQBWHOCKH-UHFFFAOYSA-N 0.000 description 1
- QVEIDMMXXOMGHZ-UHFFFAOYSA-N n-butyl-4-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCCCNC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1C QVEIDMMXXOMGHZ-UHFFFAOYSA-N 0.000 description 1
- OMWXQRPRACBVAD-UHFFFAOYSA-N n-cyclobutyloxy-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=C(F)C(F)=CC=C1C(=O)NOC1CCC1 OMWXQRPRACBVAD-UHFFFAOYSA-N 0.000 description 1
- GNBCJLIYQMNLNA-UHFFFAOYSA-N n-cyclopropyl-5-iodo-2-(4-iodo-2-methylanilino)benzamide Chemical compound CC1=CC(I)=CC=C1NC1=CC=C(I)C=C1C(=O)NC1CC1 GNBCJLIYQMNLNA-UHFFFAOYSA-N 0.000 description 1
- MBSHGFWRDZJDMZ-UHFFFAOYSA-N n-ethoxy-3,4-difluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1C MBSHGFWRDZJDMZ-UHFFFAOYSA-N 0.000 description 1
- CDOZIVZPNPKUPY-UHFFFAOYSA-N n-ethyl-4-fluoro-2-(4-iodo-2-methylanilino)benzamide Chemical compound CCNC(=O)C1=CC=C(F)C=C1NC1=CC=C(I)C=C1C CDOZIVZPNPKUPY-UHFFFAOYSA-N 0.000 description 1
- QAMBBWKIAJFFRF-UHFFFAOYSA-N n-hydroxy-2-(4-iodoanilino)benzamide Chemical class ONC(=O)C1=CC=CC=C1NC1=CC=C(I)C=C1 QAMBBWKIAJFFRF-UHFFFAOYSA-N 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 1
- 125000005487 naphthalate group Chemical group 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 125000004971 nitroalkyl group Chemical group 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 229940039748 oxalate Drugs 0.000 description 1
- 125000005429 oxyalkyl group Chemical group 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 239000012026 peptide coupling reagents Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000007388 punch biopsy Methods 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 1
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- KHVCOYGKHDJPBZ-WDCZJNDASA-N tetrahydrooxazine Chemical compound OC[C@H]1ONC[C@@H](O)[C@@H]1O KHVCOYGKHDJPBZ-WDCZJNDASA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 description 1
- 125000005297 thienyloxy group Chemical group S1C(=CC=C1)O* 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 230000006453 vascular barrier function Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000012130 whole-cell lysate Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28988101P | 2001-05-09 | 2001-05-09 | |
| US60289881 | 2001-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3821502A true AU3821502A (en) | 2002-11-14 |
Family
ID=23113527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU38215/02A Abandoned AU3821502A (en) | 2001-05-09 | 2002-05-07 | Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6972298B2 (enExample) |
| EP (1) | EP1262176A1 (enExample) |
| JP (1) | JP2002332247A (enExample) |
| KR (1) | KR20020085852A (enExample) |
| CN (1) | CN1383823A (enExample) |
| AU (1) | AU3821502A (enExample) |
| CA (1) | CA2385412A1 (enExample) |
| HU (1) | HUP0201542A3 (enExample) |
| IL (1) | IL149462A0 (enExample) |
| NZ (1) | NZ518726A (enExample) |
| PL (1) | PL353785A1 (enExample) |
| ZA (1) | ZA200203668B (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7632866B2 (en) * | 2002-10-21 | 2009-12-15 | Ramot At Tel Aviv University | Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
| WO2005007616A1 (en) * | 2003-07-23 | 2005-01-27 | Warner-Lambert Company Llc | Diphenylamino ketone derivatives as mek inhibitors |
| WO2005028426A1 (ja) * | 2003-09-19 | 2005-03-31 | Chugai Seiyaku Kabushiki Kaisha | 新規４−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用 |
| CN100594212C (zh) * | 2003-10-21 | 2010-03-17 | 沃纳-兰伯特公司 | N-[(r)-2,3-二羟基-丙氧基]-3,4-二氟-2-(2-氟-4-碘苯基氨基)-苯甲酰胺的多晶型物 |
| PT1761528E (pt) | 2004-06-11 | 2008-04-15 | Japan Tobacco Inc | Derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetra-hidro-2hpirido[ 2,3-d]pirimidina e compostos relacionados para o tratamento do cancro |
| US7378423B2 (en) | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
| MY144232A (en) | 2004-07-26 | 2011-08-15 | Chugai Pharmaceutical Co Ltd | 5-substituted-2-phenylamino benzamides as mek inhibitors |
| WO2006061712A2 (en) * | 2004-12-10 | 2006-06-15 | Pfizer Inc. | Use of mek inhibitors in treating abnormal cell growth |
| EP1934174B1 (en) | 2005-10-07 | 2011-04-06 | Exelixis, Inc. | Azetidines as mek inhibitors for the treatment of proliferative diseases |
| EP2049493B1 (en) | 2006-07-31 | 2012-03-21 | Cadila Healthcare Limited | Compounds suitable as modulators of hdl |
| JP5311673B2 (ja) | 2006-12-14 | 2013-10-09 | エグゼリクシス， インコーポレイテッド | Ｍｅｋ阻害剤の使用方法 |
| US20110071125A1 (en) * | 2007-05-11 | 2011-03-24 | Joachim Rudolph | Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| CN101868443A (zh) * | 2007-09-20 | 2010-10-20 | 特拉维夫大学拉莫特有限公司 | N-苯基邻氨基苯甲酸衍生物及其用途 |
| MX358640B (es) | 2008-01-04 | 2018-08-29 | Intellikine Llc | Isoquinolin-1 (2h) -onas y tieno [2,3-d]pirimidin-4(3h) -onas substituidas, y metodos de uso de las mismas. |
| US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| EP2475659B1 (en) | 2009-09-08 | 2015-10-28 | F.Hoffmann-La Roche Ag | 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| PH12012501361A1 (en) | 2009-12-31 | 2012-10-22 | Centro Nac De Investigaciones Oncologicas Cnio | Tricyclic compounds for use as kinase inhibitors |
| EP2526102B1 (en) | 2010-01-22 | 2017-03-08 | Fundación Centro Nacional de Investigaciones Oncológicas Carlos III | Inhibitors of PI3 kinase |
| JP2013519719A (ja) | 2010-02-18 | 2013-05-30 | セントロ ナシオナル デ インベスティガシオネス オンコロヒカス（セエネイオ） | トリアゾロ［４，５−ｂ］ピリジン誘導体 |
| WO2011121317A1 (en) | 2010-04-01 | 2011-10-06 | Centro Nacional De Investigaciones Oncologicas (Cnio) | Imidazo [2,1-b] [1,3,4] thiadiazoles as protein or lipid kinase inhibitors |
| US20150141380A1 (en) | 2010-08-05 | 2015-05-21 | Case Western Reserve University | Inhibitors of erk for developmental disorders of neuronal connectivity |
| US20120095060A1 (en) * | 2010-10-14 | 2012-04-19 | Hardie William D | Methods and compositions of mitogen-activated protein kinase (mapk) pathway inhibitors for treating pulmonary fibrosis |
| WO2012052745A1 (en) | 2010-10-21 | 2012-04-26 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Combinations of pi3k inhibitors with a second anti -tumor agent |
| TWI546305B (zh) | 2011-01-10 | 2016-08-21 | 英菲尼提製藥股份有限公司 | 製備異喹啉酮之方法及異喹啉酮之固體形式 |
| WO2012098387A1 (en) | 2011-01-18 | 2012-07-26 | Centro Nacional De Investigaciones Oncológicas (Cnio) | 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors |
| CA2831922C (en) | 2011-04-01 | 2019-12-31 | Genentech, Inc. | Combinations of akt inhibitor compounds and vemurafenib, and methods of use |
| EP2524918A1 (en) | 2011-05-19 | 2012-11-21 | Centro Nacional de Investigaciones Oncológicas (CNIO) | Imidazopyrazines derivates as kinase inhibitors |
| CA2872979C (en) | 2011-05-19 | 2020-02-18 | Joaquin Pastor Fernandez | Macrocyclic compounds as protein kinase inhibitors |
| WO2013004984A1 (en) | 2011-07-07 | 2013-01-10 | Centro Nacional De Investigaciones Oncologicas (Cnio) | Tricyclic compounds for use as kinase inhibitors |
| WO2013005057A1 (en) | 2011-07-07 | 2013-01-10 | Centro Nacional De Investigaciones Oncológicas (Cnio) | New compounds |
| WO2013005041A1 (en) | 2011-07-07 | 2013-01-10 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Tricyclic heterocyclic compounds as kinase inhibitors |
| AR087405A1 (es) | 2011-08-01 | 2014-03-19 | Genentech Inc | Metodos para tratar el cancer por el uso de antagonistas de union al eje pd-1 e inhibidores de mek |
| US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
| HRP20180670T1 (hr) | 2012-10-12 | 2018-07-13 | Exelixis Inc. | Novi postupak dobivanja spojeva namijenjenih upotrebi u liječenju raka |
| CN105102000B (zh) | 2012-11-01 | 2021-10-22 | 无限药品公司 | 使用pi3激酶亚型调节剂的癌症疗法 |
| US20140120060A1 (en) * | 2012-11-01 | 2014-05-01 | Infinity Pharmaceuticals, Inc. | Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitors |
| US11465978B2 (en) * | 2013-09-11 | 2022-10-11 | The Administrators Of The Tulane Educational Fund | Anthranilic amides and the use thereof |
| WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
| AR101210A1 (es) | 2014-07-15 | 2016-11-30 | Genentech Inc | Métodos de tratamiento de cáncer usando antagonistas de unión al eje pd-1 e inhibidores de mek |
| EP3474856B1 (en) | 2016-06-24 | 2022-09-14 | Infinity Pharmaceuticals, Inc. | Combination therapies |
| UA125400C2 (uk) * | 2016-11-18 | 2022-03-02 | Цистік Фіброзис Фаундейшн | Піролопіримідин як потенціатор трансмембранної провідності при муковісцидозі (cftr) |
| CA3077659A1 (en) * | 2017-10-09 | 2019-04-18 | Ramot At Tel-Aviv University Ltd. | Modulators of potassium ion and trpv1 channels and uses thereof |
| WO2019204569A1 (en) * | 2018-04-20 | 2019-10-24 | Thomas Jefferson University | METHOD OF USING MeK INHIBITOR TO PREVENT RADIATION INDUCED FIBROSIS |
| TW202342018A (zh) | 2022-03-04 | 2023-11-01 | 美商奇奈特生物製藥公司 | Mek激酶抑制劑 |
| WO2025043043A2 (en) * | 2023-08-24 | 2025-02-27 | Musc Foundation For Research Development | Mek1 inhibitors and uses thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525625A (en) * | 1995-01-24 | 1996-06-11 | Warner-Lambert Company | 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders |
| AU5610398A (en) * | 1997-02-28 | 1998-09-18 | Warner-Lambert Company | Method of treating or preventing septic shock by administering a mek inhibitor |
| JP2002509536A (ja) * | 1997-07-01 | 2002-03-26 | ワーナー−ランバート・カンパニー | ２−（４−ブロモ又は４−ヨードフェニルアミノ）安息香酸誘導体及びｍｅｋ阻害物質としてのそれらの使用 |
| JP2002511092A (ja) * | 1997-07-01 | 2002-04-09 | ワーナー−ランバート・コンパニー | ４−ブロモまたは４−ヨードフェニルアミノベンズヒドロキサム酸誘導体およびそのｍｅｋ阻害剤としての使用 |
| GB9726851D0 (en) * | 1997-12-19 | 1998-02-18 | Zeneca Ltd | Human signal transduction serine/threonine kinase |
| AU1951499A (en) * | 1998-01-06 | 1999-07-26 | General Hospital Corporation, The | Use of mek1 inhibitors as protective agents against damage due to ischemia |
| HUP0104607A3 (en) | 1998-12-15 | 2002-12-28 | Warner Lambert Co | Use of a mek inhibitor for preventing transplant rejection |
| CA2346448A1 (en) | 1998-12-16 | 2000-06-22 | Warner-Lambert Company | Treatment of arthritis with mek inhibitors |
| DE69928568T2 (de) | 1998-12-22 | 2006-07-27 | Warner-Lambert Co. Llc | Chemotheriapie mit einem antimitotischen mittel und einem mek inhibitor |
| CA2350234A1 (en) * | 1999-01-07 | 2000-07-13 | Alexander James Bridges | Treatment of asthma with mek inhibitors |
| EP1140067A1 (en) | 1999-01-07 | 2001-10-10 | Warner-Lambert Company | Antiviral method using mek inhibitors |
| EP1144371B1 (en) * | 1999-01-13 | 2005-11-09 | Warner-Lambert Company Llc | Benzenesulphonamide derivatives and their use as mek inhibitors |
| AU5786000A (en) | 1999-07-16 | 2001-02-05 | Warner-Lambert Company | Method for treating chronic pain using mek inhibitors |
| DE10017480A1 (de) | 2000-04-07 | 2001-10-11 | Transmit Technologietransfer | Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren |
| KR100785363B1 (ko) * | 2000-04-25 | 2007-12-18 | 이코스 코포레이션 | 인간 포스파티딜-이노시톨 3-키나제 델타의 억제제 |
| IL153817A0 (en) * | 2000-07-19 | 2003-07-31 | Warner Lambert Co | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| US20040122058A1 (en) | 2001-03-06 | 2004-06-24 | Dorian Bevec | Use of specific compounds particularly kinase inhibitors for treating viral infections |
| AU2002255852B2 (en) | 2001-03-22 | 2006-11-09 | Van Andel Research Institute | Anthrax lethal factor inhibits tumor growth and angiogenesis |
-
2002
- 2002-05-02 IL IL14946202A patent/IL149462A0/xx unknown
- 2002-05-02 NZ NZ518726A patent/NZ518726A/en unknown
- 2002-05-03 EP EP02009344A patent/EP1262176A1/en not_active Withdrawn
- 2002-05-06 CA CA002385412A patent/CA2385412A1/en not_active Abandoned
- 2002-05-07 AU AU38215/02A patent/AU3821502A/en not_active Abandoned
- 2002-05-08 KR KR1020020025328A patent/KR20020085852A/ko not_active Ceased
- 2002-05-08 HU HU0201542A patent/HUP0201542A3/hu unknown
- 2002-05-08 JP JP2002132822A patent/JP2002332247A/ja active Pending
- 2002-05-08 ZA ZA200203668A patent/ZA200203668B/xx unknown
- 2002-05-09 PL PL02353785A patent/PL353785A1/xx not_active Application Discontinuation
- 2002-05-09 CN CN02118988A patent/CN1383823A/zh active Pending
- 2002-05-09 US US10/144,315 patent/US6972298B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20030055095A1 (en) | 2003-03-20 |
| CA2385412A1 (en) | 2002-11-09 |
| CN1383823A (zh) | 2002-12-11 |
| HU0201542D0 (enExample) | 2002-07-29 |
| ZA200203668B (en) | 2002-12-20 |
| EP1262176A1 (en) | 2002-12-04 |
| HUP0201542A3 (en) | 2003-10-28 |
| HUP0201542A2 (hu) | 2003-01-28 |
| JP2002332247A (ja) | 2002-11-22 |
| NZ518726A (en) | 2004-06-25 |
| US6972298B2 (en) | 2005-12-06 |
| PL353785A1 (en) | 2002-11-18 |
| IL149462A0 (en) | 2002-11-10 |
| KR20020085852A (ko) | 2002-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6972298B2 (en) | Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor | |
| US6251943B1 (en) | Method of treating or preventing septic shock by administering a MEK inhibitor | |
| AU776788B2 (en) | Treatment of arthritis with MEK inhibitors | |
| ZA200104000B (en) | Antiviral method using MEK inhibitors. | |
| EP1140062B1 (en) | Treatment of asthma with mek inhibitors | |
| JP2017524735A (ja) | ヒストンデアセチラーゼ阻害剤による白血病の治療 | |
| JP2017537164A (ja) | リンパ腫の治療に使用されるヒストン脱アセチル化酵素阻害剤とベンダムスチンとの組み合わせ | |
| CA2346684A1 (en) | Use of a mek inhibitor for preventing transplant rejection | |
| CA2352326A1 (en) | Combination chemotherapy | |
| BRPI0609915A2 (pt) | métodos para tratar aterosclerose | |
| US20040171632A1 (en) | Combination chemotherapy | |
| AU4653299A (en) | Therapeutic agents for allergic diseases | |
| KR20240142433A (ko) | 폐 장애를 치료하기 위한 조성물 및 방법 | |
| US20200231545A1 (en) | Charged ion channel blockers and methods for use thereof |